Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Tuberculosis

  Free Subscription


Articles published in Int J Tuberc Lung Dis

Retrieve available abstracts of 853 articles:
HTML format



Single Articles


    June 2021
  1. AGOSTINIS A, Heffernan C, Long R, Beckon A, et al
    Interferon-gamma release assays for latent tuberculosis infection screening in Canadian federal correctional facilities.
    Int J Tuberc Lung Dis. 2021;25:447-452.
    PubMed     Abstract available


  2. TEO AKJ, Ong CWM, Hsu LY
    COVID-19 and TB: a progression-regression conundrum.
    Int J Tuberc Lung Dis. 2021;25:421-423.
    PubMed    


    May 2021
  3. ZOKUFA N, Lebelo K, Hacking D, Tabo L, et al
    Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era.
    Int J Tuberc Lung Dis. 2021;25:406-408.
    PubMed    


  4. POLLOCK NR, MacIntyre AT, Blauwkamp TA, Blair L, et al
    Detection of Mycobacterium tuberculosis cell-free DNA to diagnose TB in pediatric and adult patients.
    Int J Tuberc Lung Dis. 2021;25:403-405.
    PubMed    


  5. MIN J, Kang JY, Kim J, Yang J, et al
    Impact of COVID-19 on TB services in Korea.
    Int J Tuberc Lung Dis. 2021;25:400-402.
    PubMed    


  6. MARGINEANU I, Mor Z, Garcia D, Gilpin C, et al
    TB and COVID-19 in migrants - the need to focus on both conditions.
    Int J Tuberc Lung Dis. 2021;25:333-335.
    PubMed    


  7. MCQUAID CF, Foster N, Quaife M, Levy J, et al
    Digital adherence technology for TB: focus on livelihoods as well as lives.
    Int J Tuberc Lung Dis. 2021;25:416-417.
    PubMed    


  8. RICCARDI N, Saderi L, Borroni E, Tagliani E, et al
    Therapeutic strategies and outcomes of MDR and pre-XDR-TB in Italy: a nationwide study.
    Int J Tuberc Lung Dis. 2021;25:395-399.
    PubMed     Abstract available


  9. KALEMA N, Semeere A, Banturaki G, Kyamugabwa A, et al
    Gaps in TB preventive therapy for persons initiating antiretroviral therapy in Uganda: an explanatory sequential cascade analysis.
    Int J Tuberc Lung Dis. 2021;25:388-394.
    PubMed     Abstract available


  10. SATYANARAYANA S, Bhatia V, Mandal PP, Kanchar A, et al
    Urgent need to address the slow scale-up of TB preventive treatment in the WHO South-East Asia Region.
    Int J Tuberc Lung Dis. 2021;25:382-387.
    PubMed     Abstract available


  11. FERREIRO L, Ruano-Ravina A, Otero-Mallo R, Pou-Alvarez C, et al
    Recent epidemiological trends in extrapulmonary TB in Galicia, Spain.
    Int J Tuberc Lung Dis. 2021;25:373-381.
    PubMed     Abstract available


  12. WEYENGA H, Karanja M, Onyango E, Katana AK, et al
    Can isoniazid preventive therapy be scaled up rapidly? Lessons learned in Kenya, 2014-2018.
    Int J Tuberc Lung Dis. 2021;25:367-372.
    PubMed     Abstract available


  13. MARTSON AG, Kim HY, Marais B, Alffenaar JW, et al
    The importance of pharmacokinetics/pharmacodynamics assessment in Phase IIB/III trials for MDR-TB treatment.
    Int J Tuberc Lung Dis. 2021;25:336-339.
    PubMed    


    April 2021
  14. MALABAD JCM, Ang CF, Palabrica FAR, Cajucom MAM, et al
    Molecular epidemiology of Mycobacterium tuberculosis in adult Filipino TB-HIV co-infected patients.
    Int J Tuberc Lung Dis. 2021;25:285-291.
    PubMed     Abstract available


  15. HARRIES AD, Kumar AMV, Satyanarayana S, Thekkur P, et al
    TB and COVID-19: measuring key risk factors that affect treatment outcomes.
    Int J Tuberc Lung Dis. 2021;25:329-331.
    PubMed    


  16. COX V, Guglielmetti L, Hewison C, Reuter A, et al
    Reply to: "Human rights: finding the right balance for rifampicin-resistant TB treatment".
    Int J Tuberc Lung Dis. 2021;25:328-329.
    PubMed    


  17. VAN DEUN A, Piubello A, Lynen L, de Jong BC, et al
    Human rights: finding the right balance for rifampicin-resistant TB treatment.
    Int J Tuberc Lung Dis. 2021;25:327-328.
    PubMed    


  18. GULLON-BLANCO JA, Rodrigo-Sanz T, Alvarez-Navascues F, Tabernero-Huguet E, et al
    Completion of treatment for latent TB infection in a low prevalence setting.
    Int J Tuberc Lung Dis. 2021;25:321-323.
    PubMed    


  19. ROY N, Krishnamoorthy Y, Rajaa S, Ezhumalai K, et al
    Health-related quality of life and its effect on TB treatment outcomes.
    Int J Tuberc Lung Dis. 2021;25:318-320.
    PubMed    


  20. BHERING M, Duarte R, Kritski A
    Treatment outcomes and predictive factors for multidrug-resistant TB and HIV coinfection in Rio de Janeiro State, Brazil.
    Int J Tuberc Lung Dis. 2021;25:292-298.
    PubMed     Abstract available


  21. CHESOV D, Butov D, Reimann M, Heyckendorf J, et al
    Impact of lung function on treatment outcome in patients with TB.
    Int J Tuberc Lung Dis. 2021;25:277-284.
    PubMed     Abstract available


  22. VISCA D, D Ambrosio L, Centis R, Pontali E, et al
    Post-TB disease: a new topic for investigation-and why it matters.
    Int J Tuberc Lung Dis. 2021;25:258-261.
    PubMed    


  23. LAU A, Ferrara G
    Disseminated TB: still being missed and misunderstood.
    Int J Tuberc Lung Dis. 2021;25:255-257.
    PubMed    


  24. SCHULTINK MP, Kerstjens HAM, Ter Beek L, Zondag H, et al
    Assessment of TB treatment on patient well-being.
    Int J Tuberc Lung Dis. 2021;25:315-317.
    PubMed    


    March 2021
  25. KUMAR MS, Surendran D, Manu MS, Rakesh PS, et al
    Mortality due to TB-COVID-19 coinfection in India.
    Int J Tuberc Lung Dis. 2021;25:250-251.
    PubMed    


  26. GRACIAA DS, Kempker RR, Sanikidze E, Tukvadze S, et al
    TB research amidst the COVID-19 pandemic.
    Int J Tuberc Lung Dis. 2021;25:167-170.
    PubMed    


  27. ALLWOOD BW, van der Zalm MM, Mortimer K
    Reply to "Clinical care for patients with post TB lung disease".
    Int J Tuberc Lung Dis. 2021;25:253-254.
    PubMed    


  28. GUNTHER G, Ithete S
    Clinical care for patients with post-TB lung disease.
    Int J Tuberc Lung Dis. 2021;25:252-253.
    PubMed    


  29. PARK JH, Jung J, Kim JY, Hong MJ, et al
    Airborne precautions based on Xpert((R)) MTB/RIF results for patients with presumptive TB.
    Int J Tuberc Lung Dis. 2021;25:244-246.
    PubMed    


  30. KIZNY GORDON A, Tong SYC, Martinez E, Crighton T, et al
    TB genomic surveillance and data sharing in recognising contamination events.
    Int J Tuberc Lung Dis. 2021;25:241-243.
    PubMed    


  31. BAIK Y, Nalutaaya A, Kitonsa PJ, Dowdy DW, et al
    Infection status of contacts is not associated with severity of TB in the index case.
    Int J Tuberc Lung Dis. 2021;25:237-240.
    PubMed    


  32. ADANKWAH E, Arthur RA, Minadzi D, Owusu DO, et al
    Immune response against TB and non-tuberculous mycobacterial pulmonary disease.
    Int J Tuberc Lung Dis. 2021;25:234-236.
    PubMed    


  33. MALIK AA, Fuad J, Abbass W, Ikhlaque S, et al
    Preventive treatment of drug-resistant TB in a rural setting.
    Int J Tuberc Lung Dis. 2021;25:231-233.
    PubMed    


  34. CATES L, Crudu V, Codreanu A, Ciobanu N, et al
    Laboratory costs of diagnosing TB in a high multidrug-resistant TB setting.
    Int J Tuberc Lung Dis. 2021;25:228-230.
    PubMed    


  35. COX SR, Gupte AN, Thomas B, Gaikwad S, et al
    Unhealthy alcohol use independently associated with unfavorable TB treatment outcomes among Indian men.
    Int J Tuberc Lung Dis. 2021;25:182-190.
    PubMed     Abstract available


  36. SOHN H, Sweeney S, Mudzengi D, Creswell J, et al
    Determining the value of TB active case-finding: current evidence and methodological considerations.
    Int J Tuberc Lung Dis. 2021;25:171-181.
    PubMed     Abstract available


    February 2021
  37. BARRETT J, Painter H, Rajgopal A, Keane D, et al
    Increase in disseminated TB during the COVID-19 pandemic.
    Int J Tuberc Lung Dis. 2021;25:160-166.
    PubMed    


  38. ALLWOOD BW, van der Zalm MM, Mortimer K
    Reply to: Taking action to improve post-TB lung health.
    Int J Tuberc Lung Dis. 2021;25:163a-163.
    PubMed    


  39. HARRIES AD, Dlodlo RA, Brigden G, Chakaya JM, et al
    Taking action to improve post-TB lung health.
    Int J Tuberc Lung Dis. 2021;25:161-162.
    PubMed    


  40. MOLINA-MOYA B, Guglielmetti L, Bothamley G, van Leth F, et al
    Use and impact of molecular methods for detecting drug-resistant TB.
    Int J Tuberc Lung Dis. 2021;25:157-159.
    PubMed    


  41. LAW WS, Chan CKA, Leung CC
    Management of latent TB infection in child household contacts aged under 5 years.
    Int J Tuberc Lung Dis. 2021;25:151-153.
    PubMed    


  42. MEHTA SN, Murrill M, Suryavanshi N, Bhosale R, et al
    TB-related knowledge and stigma among pregnant women in low-resource settings.
    Int J Tuberc Lung Dis. 2021;25:148-150.
    PubMed    


  43. ARSCOTT-MILLS T, Ejelonu A, Mokalane K, Machao G, et al
    One third of child TB cases were missing from the national TB register in Botswana.
    Int J Tuberc Lung Dis. 2021;25:142-144.
    PubMed    


  44. DE VOS E, Scott L, Voss De Lima Y, Warren RM, et al
    Management of rifampicin-resistant TB: programme indicators and care cascade analysis in South Africa.
    Int J Tuberc Lung Dis. 2021;25:134-141.
    PubMed     Abstract available


  45. SOTGIU G, Rosales-Klintz S, Centis R, D'Ambrosio L, et al
    TB management in the European Union/European Economic Area: a multi-centre survey.
    Int J Tuberc Lung Dis. 2021;25:126-133.
    PubMed     Abstract available


  46. FOX GJ, Johnston JC, Nguyen TA, Majumdar SS, et al
    Active case-finding in contacts of people with TB.
    Int J Tuberc Lung Dis. 2021;25:95-105.
    PubMed     Abstract available


  47. LINH NN, Miller C, Marks GB
    Potential benefits of active case finding to reduce the burden of TB.
    Int J Tuberc Lung Dis. 2021;25:93-94.
    PubMed    


    January 2021
  48. SHEN X, Sha W, Yang C, Pan Q, et al
    Continuity of TB services during the COVID-19 pandemic in China.
    Int J Tuberc Lung Dis. 2021;25:81-83.
    PubMed    



  49. TB and COVID-19 co-infection: rationale and aims of a global study.
    Int J Tuberc Lung Dis. 2021;25:78-80.
    PubMed    


  50. MAUG AKJ, Hossain MA, Gumusboga M, Decroo T, et al
    Finding the right balance between efficacy and tolerability for TB treatment: the search continues.
    Int J Tuberc Lung Dis. 2021;25:84-86.
    PubMed    


  51. PARIGI S, Venturini E, Galli L, Chiappini E, et al
    Xpert((R)) MTB/RIF Ultra performance in diagnosing paediatric pulmonary TB in gastric aspirates.
    Int J Tuberc Lung Dis. 2021;25:75-77.
    PubMed    


  52. SAKR CJ, Musharrafieh UM, Banna HS, Hoteit RA, et al
    Risks and benefits of QuantiFERON((R))-TB testing for LTBI screening of health workers.
    Int J Tuberc Lung Dis. 2021;25:72-74.
    PubMed    


  53. GENDERINI FG, Dauby N, Delforge M, De Wit S, et al
    TB in the intensive care unit in a low-endemic country.
    Int J Tuberc Lung Dis. 2021;25:69-71.
    PubMed    


  54. NABISERE R, Arinaitwe A, Muyise R, Asienzo J, et al
    Implementation of TB preventive therapy in Uganda: effect of an intervention on completion rates.
    Int J Tuberc Lung Dis. 2021;25:64-65.
    PubMed    


  55. TUCKER A, Oyuku D, Nalugwa T, Nantale M, et al
    Costs along the TB diagnostic pathway in Uganda.
    Int J Tuberc Lung Dis. 2021;25:61-63.
    PubMed    


  56. MAVE V, Kadam D, Gaikwad S, Kinikar A, et al
    Measuring TB drug levels in the hair in adults and children to monitor drug exposure and outcomes.
    Int J Tuberc Lung Dis. 2021;25:52-60.
    PubMed     Abstract available


  57. MESFIN AB, Araia ZZ, Beyene HN, Mebrahtu AH, et al
    First molecular-based anti-TB drug resistance survey in Eritrea.
    Int J Tuberc Lung Dis. 2021;25:43-51.
    PubMed     Abstract available


  58. SENEADZA NAH, Antwi S, Yang H, Enimil A, et al
    Effect of malnutrition on the pharmacokinetics of anti-TB drugs in Ghanaian children.
    Int J Tuberc Lung Dis. 2021;25:36-42.
    PubMed     Abstract available


  59. WROHAN I, Redwood L, Ho J, Velen K, et al
    Ototoxicity among multidrug-resistant TB patients: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2021;25:23-30.
    PubMed     Abstract available


  60. SOH AZ, Tan CTY, Mok E, Chee CBE, et al
    Adipokines and the risk of active TB: a nested case-control study.
    Int J Tuberc Lung Dis. 2021;25:31-35.
    PubMed     Abstract available


    December 2020
  61. ZHANG H, Cao X, Wang D, Xin H, et al
    The acquisition of Mycobacterium tuberculosis infection in village doctors in China: a prospective study.
    Int J Tuberc Lung Dis. 2020;24:1241-1246.
    PubMed     Abstract available


  62. FANG JL, Chao CM, Tang HJ
    The impact of COVID-19 on the diagnosis of TB in Taiwan.
    Int J Tuberc Lung Dis. 2020;24:1321-1322.
    PubMed    


  63. SINGH J, Ehtesham NZ, Hasnain SE
    Two parallel pandemics: the challenges faced by countries with COVID-19 and TB.
    Int J Tuberc Lung Dis. 2020;24:1319-1320.
    PubMed    


    November 2020
  64. FATIMA R, Yaqoob A
    In Reply: How TB and COVID-19 compare: an opportunity to integrate both control programmes.
    Int J Tuberc Lung Dis. 2020;24:1227-1228.
    PubMed    


  65. DE SOUZA CDF, Coutinho HS, Costa MM, Magalhaes MAFM, et al
    Impact of COVID-19 on TB diagnosis in Northeastern Brazil.
    Int J Tuberc Lung Dis. 2020;24:1220-1222.
    PubMed    


  66. ZHOU S, Van Staden Q, Toska E
    Resource reprioritisation amid competing health risks for TB and COVID-19.
    Int J Tuberc Lung Dis. 2020;24:1215-1216.
    PubMed    


  67. KADOTA JL, Reza TF, Nalugwa T, Kityamuwesi A, et al
    Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic.
    Int J Tuberc Lung Dis. 2020;24:1212-1214.
    PubMed    


  68. HAAS MK, Ignatius EH, Stout JE, Dooley KE, et al
    Finding the right balance between efficacy and tolerability for TB treatment.
    Int J Tuberc Lung Dis. 2020;24:1225b-1226.
    PubMed    


  69. WANG EY, Ahluwalia IB, Mase SR
    Response to Correspondence: The impact of smoking on TB treatment outcomes includes recurrent TB.
    Int J Tuberc Lung Dis. 2020;24:1225a-1225.
    PubMed    


  70. DHAMGAYE TM
    In reply: Latent TB treatment in pregnant women: a patient perspective.
    Int J Tuberc Lung Dis. 2020;24:1226-1227.
    PubMed    


  71. CHIANG CY, Bam TS
    The impact of smoking on TB treatment outcomes includes recurrent TB.
    Int J Tuberc Lung Dis. 2020;24:1224-1225.
    PubMed    


    October 2020
  72. KIM HW, Min J, Shin AY, Koo HK, et al
    Reasons why patients with tuberculosis in South Korea stop anti-TB treatment: a cross-sectional study.
    Int J Tuberc Lung Dis. 2020;24:1016-1023.
    PubMed     Abstract available


  73. SHAHRIARIRAD R, Fallahi MJ
    TB and the COVID-19 pandemic: brothers in arms against lung health.
    Int J Tuberc Lung Dis. 2020;24:1126-1127.
    PubMed    


  74. WU Z, Chen J, Xia Z, Pan Q, et al
    Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China.
    Int J Tuberc Lung Dis. 2020;24:1122-1124.
    PubMed    


  75. MENEGUIM AC, Rebello L, Das M, Ravi S, et al
    Adapting TB services during the COVID-19 pandemic in Mumbai, India.
    Int J Tuberc Lung Dis. 2020;24:1119-1121.
    PubMed    


  76. HELDAL E, Dlodlo RA
    Estimating subnational TB burden-why not strengthen and use routine recording and reporting?
    Int J Tuberc Lung Dis. 2020;24:1125-1127.
    PubMed    


  77. AKKERMAN OW, Tiberi S
    The importance of knowing why TB patients stop anti-TB treatment.
    Int J Tuberc Lung Dis. 2020;24:989-990.
    PubMed    


    September 2020
  78. YASSIN M, Grzemska M
    Response to 'The Green Light Committee could contribute to ending tuberculosis .
    Int J Tuberc Lung Dis. 2020;24:984.
    PubMed    


  79. NGUYEN TBP, Nguyen TA, Luu BK, Le TTO, et al
    A comparison of digital chest radiography and Xpert((R)) MTB/RIF in active case finding for tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:934-940.
    PubMed     Abstract available


  80. CHIANG CH, Lee GH, Chiang TH, Tang PU, et al
    Disseminated Mycobacterium avium complex infection as a differential diagnosis of tuberculosis in HIV patients.
    Int J Tuberc Lung Dis. 2020;24:922-927.
    PubMed     Abstract available


  81. LOVEDAY M, Hlangu S, Furin J
    Breastfeeding in women living with tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:880-891.
    PubMed     Abstract available


  82. ADEWOLE OO
    Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria.
    Int J Tuberc Lung Dis. 2020;24:981-982.
    PubMed    


  83. VAN DER WALT M, Keddy KH
    How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease.
    Int J Tuberc Lung Dis. 2020;24:978-980.
    PubMed    


  84. WILSON FA, Miller TL, Stimpson JP
    COVID-19 and TB control in immigrant communities.
    Int J Tuberc Lung Dis. 2020;24:975-977.
    PubMed    


  85. ECHEVERRIA G, Espinoza W, de Waard JH
    How TB and COVID-19 compare: an opportunity to integrate both control programmes.
    Int J Tuberc Lung Dis. 2020;24:971-974.
    PubMed    


  86. MULDER C, Nkiligi E, Kondo Z, Scholten JN, et al
    What to look for when using SUBsET for subnational TB incidence estimates.
    Int J Tuberc Lung Dis. 2020;24:983-984.
    PubMed    


  87. WANG J, Garcia-Basteiro AL
    Should vitamin D supplementation be used concomitantly with LTBI treatment?
    Int J Tuberc Lung Dis. 2020;24:875-876.
    PubMed    


    August 2020
  88. KOURA KG, Harries AD, Fujiwara PI, Dlodlo RA, et al
    COVID-19 in Africa: community and digital technologies for tuberculosis management.
    Int J Tuberc Lung Dis. 2020;24:863-865.
    PubMed    


  89. LOUIE JK, Reid M, Stella J, Agraz-Lara R, et al
    A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic.
    Int J Tuberc Lung Dis. 2020;24:860-862.
    PubMed    


  90. DEWI IMW, Soeroto AY, Putriyani G, Hanifah W, et al
    Aspergillus fumigatus-specific antibodies in patients with chronic tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:853-856.
    PubMed    


  91. SILVA LL, Valverde TL, de Carvalho Dutra A, De Andrade L, et al
    Geospatial analysis and factors associated with poor outcome for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:844-846.
    PubMed    


  92. ALLWOOD BW, van der Zalm MM, Amaral AFS, Byrne A, et al
    Post-tuberculosis lung health: perspectives from the First International Symposium.
    Int J Tuberc Lung Dis. 2020;24:820-828.
    PubMed     Abstract available


  93. CHIMEH RA, Gafar F, Pradipta IS, Akkerman OW, et al
    Clinical and economic impact of medication non-adherence in drug-susceptible tuberculosis: a systematic review.
    Int J Tuberc Lung Dis. 2020;24:811-819.
    PubMed     Abstract available


  94. SIAPKA M, Vassall A, Cunnama L, Pineda C, et al
    Cost of tuberculosis treatment in low- and middle-income countries: systematic review and meta-regression.
    Int J Tuberc Lung Dis. 2020;24:802-810.
    PubMed     Abstract available


  95. HAN X, Chen X, Sha W, Zhang X, et al
    Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis in China.
    Int J Tuberc Lung Dis. 2020;24:789-794.
    PubMed     Abstract available


  96. MCARDLE AJ, Keane D, Seddon JA, Bernatoniene J, et al
    Vitamin D deficiency is associated with tuberculosis disease in British children.
    Int J Tuberc Lung Dis. 2020;24:782-788.
    PubMed     Abstract available


  97. VISCA D, Centis R, Munoz-Torrico M, Pontali E, et al
    Post-tuberculosis sequelae: the need to look beyond treatment outcome.
    Int J Tuberc Lung Dis. 2020;24:761-762.
    PubMed    


  98. ZUMLA A, Marais BJ, McHugh TD, Maeurer M, et al
    COVID-19 and tuberculosis-threats and opportunities.
    Int J Tuberc Lung Dis. 2020;24:757-760.
    PubMed    


  99. JAMAL WZ, Habib S, Khowaja S, Safdar N, et al
    COVID-19: ensuring continuity of TB services in the private sector.
    Int J Tuberc Lung Dis. 2020;24:870-872.
    PubMed    


  100. WATTS K, McKeown A, Denholm J, Baker AM, et al
    Responding to COVID-19: adjusting TB services in a low-burden setting.
    Int J Tuberc Lung Dis. 2020;24:866-869.
    PubMed    


  101. CHIANG CY
    Green Light Committee and WHO recommendations.
    Int J Tuberc Lung Dis. 2020;24:873-874.
    PubMed    


    July 2020
  102. KUBIAK RW, Drain PK, Hochberg NS
    How should body mass index inform active tuberculosis screening in diabetes clinics in Asia?
    Int J Tuberc Lung Dis. 2020;24:753.
    PubMed    


  103. LIU C, Yu Y, Fleming J, Wang T, et al
    Severe COVID-19 cases with a history of active or latent tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:747-749.
    PubMed    


  104. BURZYNSKI J, Macaraig M, Nilsen D, Schluger NW, et al
    Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City.
    Int J Tuberc Lung Dis. 2020;24:735-736.
    PubMed    


  105. KADOTA JL, Katamba A, Musinguzi A, Welishe F, et al
    Willingness to accept reimbursement for visits to an HIV clinic for tuberculosis preventive therapy.
    Int J Tuberc Lung Dis. 2020;24:729-731.
    PubMed    


  106. CHIANG SS, Beckhorn CB, Wong M, Lecca L, et al
    Patterns of suboptimal adherence among adolescents treated for tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:723-725.
    PubMed    


  107. VISCA D, Centis R, D'Ambrosio L, Munoz-Torrico M, et al
    The need for pulmonary rehabilitation following tuberculosis treatment.
    Int J Tuberc Lung Dis. 2020;24:720-722.
    PubMed    


  108. EDWARDS T, White LV, Lee N, Castro MC, et al
    Effects of comorbidities on quality of life in Filipino people with tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:712-719.
    PubMed     Abstract available


  109. IQBAL SA, Isenhour CJ, Mazurek G, Truman BI, et al
    Diagnostic code agreement for electronic health records and claims data for tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:706-711.
    PubMed     Abstract available


  110. MUNOZ-TORRICO M, Cid-Juarez S, Gochicoa-Rangel L, Torre-Bouscolet L, et al
    Functional impact of sequelae in drug-susceptible and multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:700-705.
    PubMed     Abstract available


  111. WATTHANANUKUL T, Liabsuetrakul T, Pungrassami P, Chongsuvivatwong V, et al
    Effect of Global Fund financial support for patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:686-693.
    PubMed     Abstract available


  112. RICKMAN HM, Cohn S, Lala SG, Waja Z, et al
    Subclinical tuberculosis and adverse infant outcomes in pregnant women with HIV.
    Int J Tuberc Lung Dis. 2020;24:681-685.
    PubMed     Abstract available


  113. MADHANI F, Maniar RA, Burfat A, Ahmed M, et al
    Automated chest radiography and mass systematic screening for tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:665-673.
    PubMed     Abstract available


  114. BASHAM CA, Grewal N, Orr PH, McMullin K, et al
    What will it take to achieve meaningful action on tuberculosis among Indigenous Peoples?
    Int J Tuberc Lung Dis. 2020;24:661-664.
    PubMed    


  115. ROSSATO SILVA D, van den Hof S
    Use of insurance claims and electronic health records to assess tuberculosis and latent tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2020;24:659-660.
    PubMed    


  116. TADYANEMHANDU C, Chirenda J, Garvey C, Metcalfe J, et al
    Treatment success, but living with the consequences of post-tuberculosis sequelae.
    Int J Tuberc Lung Dis. 2020;24:657-658.
    PubMed    


  117. SCHAAF HS, du Preez K, Kruger M, Solomons R, et al
    Bacille Calmette-Guerin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed.
    Int J Tuberc Lung Dis. 2020;24:732-734.
    PubMed    


    June 2020
  118. DE SOUZA JVP, Murase LS, Caleffi-Ferracioli KR, Palomo CT, et al
    Isoniazid and verapamil modulatory activity and efflux pump gene expression in Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:591-596.
    PubMed     Abstract available


  119. GUPTA A, Singla R, Caminero JA, Singla N, et al
    Impact of COVID-19 on tuberculosis services in India.
    Int J Tuberc Lung Dis. 2020;24:637-639.
    PubMed    


  120. SANDY C, Takarinda KC, Timire C, Mutunzi H, et al
    Preparing national tuberculosis control programmes for COVID-19.
    Int J Tuberc Lung Dis. 2020;24:634-636.
    PubMed    


  121. PROOPS DC, Knorr JA, Meissner JS, Kreiswirth BN, et al
    Epidemiology of tuberculosis among healthcare personnel in New York City.
    Int J Tuberc Lung Dis. 2020;24:619-625.
    PubMed     Abstract available


  122. COCOZZA AM, Linh NN, Jaramillo E
    Is effective patient support missing in the global response to multidrug-resistant tuberculosis?
    Int J Tuberc Lung Dis. 2020;24:626-630.
    PubMed     Abstract available


  123. ONGOLE JJ, Rossouw TM, Fourie PB, Stoltz AC, et al
    Sustaining essential healthcare in Africa during the COVID-19 pandemic.
    Int J Tuberc Lung Dis. 2020;24:643-645.
    PubMed    


  124. VAN CREVEL R, Andia-Biraro I, Ntinginya NE, Chamba N, et al
    Response to IJTLD article, "Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis".
    Int J Tuberc Lung Dis. 2020;24:632-633.
    PubMed    


  125. NAMKOONG H, Horita N, Ebina-Shibuya R
    Concern over a COVID-19-related BCG shortage.
    Int J Tuberc Lung Dis. 2020;24:642-643.
    PubMed    


  126. MORAN A, Kula N, Jagwer G, Broughton E, et al
    Examining the cost of community-based tuberculosis treatment in South Africa.
    Int J Tuberc Lung Dis. 2020;24:612-618.
    PubMed     Abstract available


  127. LAZARUS JV
    Correspondence on: "Should we consider a 'fourth 90' for tuberculosis?"
    Int J Tuberc Lung Dis. 2020;24:631-632.
    PubMed    


  128. HARRIES AD
    In Response to Reinout van Crevel et al.
    Int J Tuberc Lung Dis. 2020;24:634.
    PubMed    


    May 2020
  129. PANG Y, Liu Y, Du J, Gao J, et al
    Impact of COVID-19 on tuberculosis control in China.
    Int J Tuberc Lung Dis. 2020;24:545-547.
    PubMed    


  130. DARA M, Sotgiu G, Reichler MR, Chiang CY, et al
    New diseases and old threats: lessons from tuberculosis for the COVID-19 response.
    Int J Tuberc Lung Dis. 2020;24:544-545.
    PubMed    


  131. PONTALI E, Tiberi S
    Green Light Committee and drug-resistant-tuberculosis: how to address the new challenges?
    Int J Tuberc Lung Dis. 2020;24:539.
    PubMed    


  132. HENG M, Allmendinger S, Chiang CY, Trebucq A, et al
    Progress in the roll-out of multidrug-resistant tuberculosis (MDR-TB) treatments.
    Int J Tuberc Lung Dis. 2020;24:535-536.
    PubMed    


  133. MONDONI M, Sotgiu G
    Endobronchial ultrasound-guided transbronchial needle aspiration and tuberculosis mediastinal lymphadenopathy.
    Int J Tuberc Lung Dis. 2020;24:534.
    PubMed    


  134. ARINAMINPATHY N, Chin DP, Sachdeva KS, Rao R, et al
    Modelling the potential impact of adherence technologies on tuberculosis in India.
    Int J Tuberc Lung Dis. 2020;24:526-533.
    PubMed     Abstract available


  135. GARFEIN RS, Liu L, Cuevas-Mota J, Collins K, et al
    Evaluation of recorded video-observed therapy for anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2020;24:520-525.
    PubMed     Abstract available


  136. KAWATSU L, Uchimura K, Ohkado A
    A cost-effectiveness study of tuberculosis and latent tuberculosis infection screening in prisons in Japan.
    Int J Tuberc Lung Dis. 2020;24:506-511.
    PubMed     Abstract available


  137. MAUG AKJ, Hossain MA, Gumusboga M, Decroo T, et al
    First-line tuberculosis treatment with double-dose rifampicin is well tolerated.
    Int J Tuberc Lung Dis. 2020;24:499-505.
    PubMed     Abstract available


  138. PARK SC, Kang MJ, Han CH, Lee SM, et al
    Long-term mortality of patients with tuberculosis in Korea.
    Int J Tuberc Lung Dis. 2020;24:492-498.
    PubMed     Abstract available


  139. BUTOV D, Lange C, Heyckendorf J, Kalmykova I, et al
    Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine.
    Int J Tuberc Lung Dis. 2020;24:485-491.
    PubMed     Abstract available


  140. ANDREWS JR, Cobelens F, Horsburgh CR, Hatherill M, et al
    Seasonal drivers of tuberculosis: evidence from over 100 years of notifications in Cape Town.
    Int J Tuberc Lung Dis. 2020;24:477-484.
    PubMed     Abstract available


  141. DENHOLM J
    Seasonality, climate change and tuberculosis: new data and old lessons.
    Int J Tuberc Lung Dis. 2020;24:469.
    PubMed    


  142. COX V, Wilkinson L, Grimsrud A, Hughes J, et al
    Critical changes to services for TB patients during the COVID-19 pandemic.
    Int J Tuberc Lung Dis. 2020;24:542-544.
    PubMed    


  143. ELGER BS, Mirzayev F, Afandiyev S, Gurbanova E, et al
    Ethical issues in tuberculosis screening and the use of new drugs for prisoners.
    Int J Tuberc Lung Dis. 2020;24:57-60.
    PubMed     Abstract available


  144. HERMANNS S, Bhan A, Viney K
    Ethics and benefits of systematic screening for active tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:44-47.
    PubMed     Abstract available


  145. HUMMEL P, Ahamed N, Amanullah F
    Ethical issues surrounding childhood tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:27-31.
    PubMed     Abstract available


  146. DENHOLM JT, Millan-Marcelo JC, Fiekert K
    Latent tuberculosis infection and the EndTB Strategy: ethical tensions and imperatives.
    Int J Tuberc Lung Dis. 2020;24:21-26.
    PubMed     Abstract available


  147. BAYER R, Fairchild AL, Zignol M, Castro KG, et al
    Tuberculosis surveillance and its discontents: the ethical paradox.
    Int J Tuberc Lung Dis. 2020;24:9-14.
    PubMed     Abstract available


  148. HARDING R, Snyman L, Ostgathe C, Odell S, et al
    The ethical imperative to relieve suffering for people with tuberculosis by ensuring access to palliative care.
    Int J Tuberc Lung Dis. 2020;24:3-8.
    PubMed     Abstract available


  149. FURIN J
    Can Green Light Committees help "end TB"?
    Int J Tuberc Lung Dis. 2020;24:540.
    PubMed    


    April 2020
  150. KAPUR A
    Randomised clinical trials for tuberculosis prophylaxis in people with diabetes mellitus.
    Int J Tuberc Lung Dis. 2020;24:465-466.
    PubMed    


  151. SHEDRAWY J, Jansson L, Bruchfeld J, Lonnroth K, et al
    Health-related quality of life among persons treated for tuberculosis in a European setting.
    Int J Tuberc Lung Dis. 2020;24:461-463.
    PubMed    


  152. SCHWOEBEL V, Koura KG, Adjobimey M, Gnanou S, et al
    Tuberculosis contact investigation and short-course preventive therapy among young children in Africa.
    Int J Tuberc Lung Dis. 2020;24:452-460.
    PubMed     Abstract available


  153. YOUNG C, Barker S, Ehrlich R, Kistnasamy B, et al
    Computer-aided detection for tuberculosis and silicosis in chest radiographs of gold miners of South Africa.
    Int J Tuberc Lung Dis. 2020;24:444-451.
    PubMed     Abstract available


  154. MIKIASHVILI L, Kipiani M, Schechter MC, Avaliani Z, et al
    Linezolid use for drug-resistant tuberculosis in Georgia: a retrospective cohort study.
    Int J Tuberc Lung Dis. 2020;24:436-443.
    PubMed     Abstract available


  155. PIERRE-AUDIGIER C, Talla C, Alame-Emane AK, Audigier B, et al
    Tuberculosis trends in a hot-spot region in Paris, France.
    Int J Tuberc Lung Dis. 2020;24:428-435.
    PubMed     Abstract available


  156. TOMENY EM, Mendoza VL, Marcelo DB, Barrameda AJD, et al
    Patient-cost survey for tuberculosis in the context of patient-pathway modelling.
    Int J Tuberc Lung Dis. 2020;24:420-427.
    PubMed     Abstract available


  157. O'SON L, Hulland E, Cookson ST, Castro KG, et al
    Epidemiology and risk factors for extrapulmonary tuberculosis in Lebanon.
    Int J Tuberc Lung Dis. 2020;24:414-419.
    PubMed     Abstract available


  158. GOBAUD AN, Haley CA, Wilson JW, Bhavaraju R, et al
    Multidrug-resistant tuberculosis care in the United States.
    Int J Tuberc Lung Dis. 2020;24:409-413.
    PubMed     Abstract available


  159. MCCREESH N, Grant AD, Yates TA, Karat AS, et al
    Tuberculosis from transmission in clinics in high HIV settings may be far higher than contact data suggest.
    Int J Tuberc Lung Dis. 2020;24:403-408.
    PubMed     Abstract available


  160. KIM HY, Hanrahan CF, Dowdy DW, Martinson NA, et al
    Priorities among HIV-positive individuals for tuberculosis preventive therapies.
    Int J Tuberc Lung Dis. 2020;24:396-402.
    PubMed     Abstract available


  161. MASUKU SD, Berhanu R, Van Rensburg C, Ndjeka N, et al
    Managing multidrug-resistant tuberculosis in South Africa: a budget impact analysis.
    Int J Tuberc Lung Dis. 2020;24:376-382.
    PubMed     Abstract available


  162. MILLER CR, Mitchell EMH, Nishikiori N, Zwerling A, et al
    ScreenTB: a tool for prioritising risk groups and selecting algorithms for screening for active tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:367-375.
    PubMed     Abstract available


  163. LANEY AS, Pontali E
    Computer-assisted interpretation of chest radiographs: signs of hope for silicosis and tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:362-363.
    PubMed    


  164. CRUZ AT, Schwartzman K, Kitai I
    Fighting a hidden epidemic: expanding tuberculosis preventive treatment to the youngest household contacts.
    Int J Tuberc Lung Dis. 2020;24:357-359.
    PubMed    


  165. BASHAM CA, Romanowski K, Johnston JC
    Cardiovascular disease: the forgotten cousin of post-TB health?
    Int J Tuberc Lung Dis. 2020;24:466-467.
    PubMed    


    March 2020
  166. HASKER E, Assoumani Y, Mzembaba A, Zakir AM, et al
    Using a geographic information system as a management tool for tuberculosis control.
    Int J Tuberc Lung Dis. 2020;24:354-356.
    PubMed    


  167. YATES TA, Tomlinson LA, Douglas IJ
    Proton pump inhibitors and tuberculosis risk.
    Int J Tuberc Lung Dis. 2020;24:353-354.
    PubMed    


  168. KOHLENBERG A, Kodmon C, van den Boom M, van der Werf MJ, et al
    Tuberculosis surveillance in adolescents: what to learn from European Union/European Economic Area data?
    Int J Tuberc Lung Dis. 2020;24:347-352.
    PubMed     Abstract available


  169. GUNASEKERA K, Cohen T, Gao W, Ayles H, et al
    Smoking and HIV associated with subclinical tuberculosis: analysis of a population-based prevalence survey.
    Int J Tuberc Lung Dis. 2020;24:340-346.
    PubMed     Abstract available


  170. NGABONZIZA JS, Habimana YM, Decroo T, Migambi P, et al
    Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda.
    Int J Tuberc Lung Dis. 2020;24:329-339.
    PubMed     Abstract available


  171. BONSU F, Addo KK, Alebachew Z, Gyapong J, et al
    National population-based tuberculosis prevalence survey in Ghana, 2013.
    Int J Tuberc Lung Dis. 2020;24:321-328.
    PubMed     Abstract available


  172. JANSSON L, Shedrawy J, Lonnroth K, Bruchfeld J, et al
    Latent tuberculosis in pregnant women: a patient perspective.
    Int J Tuberc Lung Dis. 2020;24:310-315.
    PubMed     Abstract available


  173. LOPEZ-MEDINA EM, Sainz T, de Ory SJ, Mellado-Pena MJ, et al
    Tuberculosis in a Spanish cohort of children living with HIV: the CHOTIS study (Childhood HIV & TB study).
    Int J Tuberc Lung Dis. 2020;24:303-309.
    PubMed     Abstract available


  174. WANG M, Liu F, Li Q, Yin Q, et al
    Quality assessment of guidelines for the management of Mycobacterium tuberculosis infection in children.
    Int J Tuberc Lung Dis. 2020;24:287-294.
    PubMed     Abstract available


  175. ARNEDO-PENA A, Juan-Cerdan JV, Romeu-Garcia M, Sorribes-Segura S, et al
    Vitamin D status and latent tuberculosis infection: conversion in nursing homes, Spain.
    Int J Tuberc Lung Dis. 2020;24:278-286.
    PubMed     Abstract available


  176. REICHLER MR, Hirsch-Moverman Y
    Antenatal diagnosis of latent tuberculosis infection and post-partum treatment: patient perspectives.
    Int J Tuberc Lung Dis. 2020;24:266-267.
    PubMed    


  177. DEDICOAT M
    Where next with for vitamin D and tuberculosis?
    Int J Tuberc Lung Dis. 2020;24:265.
    PubMed    


  178. DOWDY DW
    The urgent need to improve clinical practice guidelines for pediatric tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:264.
    PubMed    


    February 2020
  179. SINGH AR, Shewade HD, Pandey R
    Near real-time supervision of home visits for patients with tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:260-261.
    PubMed    


  180. TALBOT EA
    Response to Dr Granich's letter regarding 'Tackling drug-resistant tuberculosis: we need a critical synergy of product and process innovations'.
    Int J Tuberc Lung Dis. 2020;24:259.
    PubMed    


  181. PARWATI CG, Farid MN, Nasution HS, Basri C, et al
    Estimation of subnational tuberculosis burden: generation and application of a new tool in Indonesia.
    Int J Tuberc Lung Dis. 2020;24:250-257.
    PubMed     Abstract available


  182. PARK S, Jo KW, Shim TS
    Treatment outcomes in multidrug-resistant tuberculosis according to pyrazinamide susceptibility.
    Int J Tuberc Lung Dis. 2020;24:233-239.
    PubMed     Abstract available


  183. QUISPE N, Asencios L, Obregon C, Velasquez GE, et al
    The fourth national anti-tuberculosis drug resistance survey in Peru.
    Int J Tuberc Lung Dis. 2020;24:207-213.
    PubMed     Abstract available


  184. GATTI A, Ceriani C, De Paschale M, Magnani C, et al
    Quantification of neutrophil and monocyte CD64 expression: a predictive biomarker for active tuberculosis.
    Int J Tuberc Lung Dis. 2020;24:196-201.
    PubMed     Abstract available


  185. WANG EY, Arrazola RA, Mathema B, Ahluwalia IB, et al
    The impact of smoking on tuberculosis treatment outcomes: a meta-analysis.
    Int J Tuberc Lung Dis. 2020;24:170-175.
    PubMed     Abstract available


  186. RABKIN M, Howard AA, Ehrenkranz P, Fernandez LG, et al
    Leveraging differentiated HIV service delivery to expand tuberculosis preventive treatment: a call to action.
    Int J Tuberc Lung Dis. 2020;24:165-169.
    PubMed     Abstract available


  187. GRANICH R
    Time for hand wringing about TB diagnostics is over: show us the money and the impact.
    Int J Tuberc Lung Dis. 2020;24:258-259.
    PubMed    


    January 2020
  188. WU MY, Shu CC, Lin HH
    Authors reply to letter to the Editor "Chronic kidney disease, tuberculosis and climate change".
    Int J Tuberc Lung Dis. 2020;24:133-134.
    PubMed    


  189. HARRIES AD
    Chronic kidney disease, tuberculosis and climate change.
    Int J Tuberc Lung Dis. 2020;24:132-133.
    PubMed    


  190. LEROLLE N, Laanani M, Galicier L, Riviere S, et al
    Factors associated with tuberculosis-associated haemophagocytic syndrome: a multicentre case-control study.
    Int J Tuberc Lung Dis. 2020;24:124-130.
    PubMed     Abstract available


  191. LINH NN, Wares F, Cocozza AM, Uplekar M, et al
    No universal access to drug-resistant tuberculosis care without engaging all health care providers.
    Int J Tuberc Lung Dis. 2020;24:118-123.
    PubMed     Abstract available


  192. DESHMUKH S, Atre S, Chavan A, Raskar S, et al
    Assessment of the Xpert assay among adult pulmonary tuberculosis suspects with and without diabetes mellitus.
    Int J Tuberc Lung Dis. 2020;24:113-117.
    PubMed     Abstract available


  193. BARSS L, Moayedi-Nia S, Campbell JR, Oxlade O, et al
    Interventions to reduce losses in the cascade of care for latent tuberculosis: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2020;24:100-109.
    PubMed     Abstract available


  194. CHEN MP, Miramontes R, Kammerer JS
    Multidrug-resistant tuberculosis in the United States, 2011-2016: patient characteristics and risk factors.
    Int J Tuberc Lung Dis. 2020;24:92-99.
    PubMed     Abstract available


  195. HILL J, Dickson-Hall L, Grant AD, Grundy C, et al
    Drug-resistant tuberculosis patient care journeys in South Africa: a pilot study using routine laboratory data.
    Int J Tuberc Lung Dis. 2020;24:83-91.
    PubMed     Abstract available


  196. RAGAN EJ, Kleinman MB, Sweigart B, Gnatienko N, et al
    The impact of alcohol use on tuberculosis treatment outcomes: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2020;24:73-82.
    PubMed     Abstract available


  197. HONG H, Dowdy DW, Dooley KE, Francis HW, et al
    Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.
    Int J Tuberc Lung Dis. 2020;24:65-72.
    PubMed     Abstract available


  198. PERUMAL R, Naidoo K, Naidoo A, Ramachandran G, et al
    A systematic review and meta-analysis of first-line tuberculosis drug concentrations and treatment outcomes.
    Int J Tuberc Lung Dis. 2020;24:48-64.
    PubMed     Abstract available


  199. COCOZZA AM, Linh NN, Nathavitharana RR, Ahmad U, et al
    An assessment of current tuberculosis patient care and support policies in high-burden countries.
    Int J Tuberc Lung Dis. 2020;24:36-42.
    PubMed     Abstract available


  200. REEVES H, Grandjean Lapierre S, Razafindrina K, Andriamiadanarivo A, et al
    Evaluating the use of educational videos to support the tuberculosis care cascade in remote Madagascar.
    Int J Tuberc Lung Dis. 2020;24:28-35.
    PubMed     Abstract available


  201. GUTIERREZ C, Somoskovi A
    Serum levels of tuberculosis drugs-beyond the quantitative data.
    Int J Tuberc Lung Dis. 2020;24:6-7.
    PubMed    


  202. CHAULK CP, Moonan PK
    Over the limit: tuberculosis and excessive alcohol use.
    Int J Tuberc Lung Dis. 2020;24:3-4.
    PubMed    


    December 2019
  203. DENHOLM JT, Leontiou C, McKeown A, Watts KN, et al
    Speaking up: language services, tuberculosis and human rights.
    Int J Tuberc Lung Dis. 2019;23:1336.
    PubMed    


  204. MEKONNEN D, Derbie A, Abeje A, Shumet A, et al
    Genomic diversity and transmission dynamics of M. tuberculosis in Africa: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:1314-1326.
    PubMed     Abstract available


  205. SURIE D, Interrante JD, Pathmanathan I, Patel MR, et al
    Policies, practices and barriers to implementing tuberculosis preventive treatment-35 countries, 2017.
    Int J Tuberc Lung Dis. 2019;23:1308-1313.
    PubMed     Abstract available


  206. LIFAN Z, Sainan B, Feng S, Siyan Z, et al
    Linezolid for the treatment of extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:1293-1307.
    PubMed     Abstract available


  207. HANDEL A, Martinez L, Sekandi JN, Bellan SE, et al
    Evidence for supercoughers in an analysis of six tuberculosis cohorts from China, Peru, The Gambia and Uganda.
    Int J Tuberc Lung Dis. 2019;23:1286-1292.
    PubMed     Abstract available


  208. ZMAK L, Obrovac M, Makek MJ, Perko G, et al
    From Peruvian mummies to living humans: first case of pulmonary tuberculosis caused by Mycobacterium pinnipedii.
    Int J Tuberc Lung Dis. 2019;23:1283-1285.
    PubMed     Abstract available


  209. SOH AZ, Chee CBE, Wang YT, Yuan JM, et al
    Diabetes and body mass index in relation to risk of active tuberculosis: a prospective population-based cohort.
    Int J Tuberc Lung Dis. 2019;23:1277-1282.
    PubMed     Abstract available


  210. PENG Y, Zhu Y, Ao G, Chen Z, et al
    Effect of bronchial artery embolisation on the management of tuberculosis-related haemoptysis.
    Int J Tuberc Lung Dis. 2019;23:1269-1276.
    PubMed     Abstract available


  211. WADEMAN DT, Busakwe L, Nicholson TJ, van der Zalm M, et al
    Acceptability of a first-line anti-tuberculosis formulation for children: qualitative data from the SHINE trial.
    Int J Tuberc Lung Dis. 2019;23:1263-1268.
    PubMed     Abstract available


  212. CHANDAK RJ, Malhotra B, Bhargava S, Goel SK, et al
    Evaluation of MTBDRsl for detecting resistance in Mycobacterium tuberculosis to second-line drugs.
    Int J Tuberc Lung Dis. 2019;23:1257-1262.
    PubMed     Abstract available


  213. DUNSTAN SJ, Williamson DA, Denholm JT
    Understanding the global tuberculosis epidemic: moving towards routine whole-genome sequencing.
    Int J Tuberc Lung Dis. 2019;23:1241-1242.
    PubMed    


  214. HARRIES AD
    Having diabetes and being underweight in Asia: a potent risk factor for tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:1237-1238.
    PubMed    


  215. SUDBURY E, Villanueva P, Goetzinger F, Tebruegge M, et al
    The impact of bacille Calmette-Guerin vaccination on tuberculin skin test results in young children.
    Int J Tuberc Lung Dis. 2019;23:1335-1336.
    PubMed    


    November 2019
  216. HARRIES AD, Dlodlo RA, Brigden G, Mortimer K, et al
    Should we consider a 'fourth 90' for tuberculosis?
    Int J Tuberc Lung Dis. 2019 Nov 21. doi: 10.5588/ijtld.19.0471.
    PubMed     Abstract available


  217. TIMIRE C, Sandy C, Harries AD
    Eliminating tuberculosis by 2035: tackling the financial barriers at all stages of the cascade of care.
    Int J Tuberc Lung Dis. 2019;23:1235.
    PubMed    


  218. COIT J, Mendoza M, Pinedo C, Marin H, et al
    Performance of a household tuberculosis exposure survey among children in a Latin American setting.
    Int J Tuberc Lung Dis. 2019;23:1223-1227.
    PubMed     Abstract available


  219. RIVERA VR, Lu L, Ocheretina O, Jean Juste MA, et al
    Diagnostic yield of active case finding for tuberculosis at human immunodeficiency virus testing in Haiti.
    Int J Tuberc Lung Dis. 2019;23:1217-1222.
    PubMed     Abstract available


  220. SUMALANI KK, Akhter N, Chawla D, Rizvi NA, et al
    Diagnostic yield of sputum induction in patients with pleural tuberculosis at a tertiary care hospital in Karachi.
    Int J Tuberc Lung Dis. 2019;23:1213-1216.
    PubMed     Abstract available


  221. ERLINGER S, Stracker N, Hanrahan C, Nonyane S, et al
    Tuberculosis patients with higher levels of poverty face equal or greater costs of illness.
    Int J Tuberc Lung Dis. 2019;23:1205-1212.
    PubMed     Abstract available


  222. JORDAN AM, Podewils LJ, Castro KG, Zishiri V, et al
    Prevalence and risk factors of tuberculosis disease in South African correctional facilities in 2015.
    Int J Tuberc Lung Dis. 2019;23:1198-1204.
    PubMed     Abstract available


  223. VINEY K, Amaral S, Marques EB, Siroka A, et al
    Four of five tuberculosis patients experience catastrophic costs related to TB diagnosis and care in Timor-Leste.
    Int J Tuberc Lung Dis. 2019;23:1191-1197.
    PubMed     Abstract available


  224. AUGUSTE P, Madan J, Tsertsvadze A, Court R, et al
    Identifying latent tuberculosis in high-risk populations: systematic review and meta-analysis of test accuracy.
    Int J Tuberc Lung Dis. 2019;23:1178-1190.
    PubMed     Abstract available


  225. CADMUS S, Akinseye VO, van Soolingen D
    Mycobacterium bovis in humans and M. tuberculosis in animals in Nigeria: an overview from 1975-2014.
    Int J Tuberc Lung Dis. 2019;23:1162-1170.
    PubMed     Abstract available


  226. SCHULMAN H, Niward K, Abate E, Idh J, et al
    Sedimentation rate and suPAR in relation to disease activity and mortality in patients with tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:1155-1161.
    PubMed     Abstract available


  227. LAM CK, Fluegge K, Macaraig M, Burzynski J, et al
    Cost savings associated with video directly observed therapy for treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:1149-1154.
    PubMed     Abstract available


  228. BOCCIA D, Bond V
    The catastrophic cost of tuberculosis: advancing research and solutions.
    Int J Tuberc Lung Dis. 2019;23:1129-1130.
    PubMed    


  229. SCHON T
    The evaluation of routine immunological tests to estimate the risk of progression into active tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:1127-1128.
    PubMed    


  230. PEDRAZZOLI D, Houben R, Viney K, Lonnroth K, et al
    Beyond measurement: taking bold multisector actions towards zero catastrophic costs and suffering due to TB.
    Int J Tuberc Lung Dis. 2019;23:1236.
    PubMed    


    October 2019
  231. FIOGBE AA, Agodokpessi G, Marcy O
    In reply to: Programmatic implementation of screening and management of pulmonary impairment post-tuberculosis in resource-limited countries: challenges and feasibility.
    Int J Tuberc Lung Dis. 2019;23:1123.
    PubMed    


  232. OLIVEIRA MCB, Sant'Anna CC, Luiz RR, Soares ECC, et al
    Contribution of Xpert MTB/RIF to clinical diagnosis in adolescents with tuberculosis in Rio de Janeiro, Brazil.
    Int J Tuberc Lung Dis. 2019;23:1115-1121.
    PubMed     Abstract available


  233. CAMELIQUE O, Scholtissen S, Dousset JP, Bonnet M, et al
    Mobile community-based active case-finding for tuberculosis among older populations in rural Cambodia.
    Int J Tuberc Lung Dis. 2019;23:1107-1114.
    PubMed     Abstract available


  234. VALVI C, Chandanwale A, Khadse S, Kulkarni R, et al
    Delays and barriers to early treatment initiation for childhood tuberculosis in India.
    Int J Tuberc Lung Dis. 2019;23:1090-1099.
    PubMed     Abstract available


  235. BHERING M, Kritski A, Nunes C, Duarte R, et al
    Multidrug-resistant tuberculosis in Lisbon: unfavourable treatment and associated factors, 2000-2014.
    Int J Tuberc Lung Dis. 2019;23:1075-1081.
    PubMed     Abstract available


  236. COURT R, Chirehwa MT, Wiesner L, de Vries N, et al
    Effect of tablet crushing on drug exposure in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:1068-1074.
    PubMed     Abstract available


  237. BASTARD M, Sanchez-Padilla E, Hayrapetyan A, Kimenye K, et al
    What is the best culture conversion prognostic marker for patients treated for multidrug-resistant tuberculosis?
    Int J Tuberc Lung Dis. 2019;23:1060-1067.
    PubMed     Abstract available


  238. VINEY K, Mills T, Harley D
    Tuberculosis and diabetes mellitus: a dose-response relationship between the odds of tuberculosis and HbA1c.
    Int J Tuberc Lung Dis. 2019;23:1055-1059.
    PubMed     Abstract available


  239. GUGLIELMETTI L, Jaffre J, Bernard C, Brossier F, et al
    Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium.
    Int J Tuberc Lung Dis. 2019;23:1050-1054.
    PubMed     Abstract available


  240. PONTALI E, Tadolini M, Migliori GB
    TB consilia and quality of tuberculosis management.
    Int J Tuberc Lung Dis. 2019;23:1048-1049.
    PubMed    


  241. DOWDY DW
    Implementation of Xpert((R)) MTB/RIF: real challenges, real promise.
    Int J Tuberc Lung Dis. 2019;23:1123.
    PubMed    


  242. TADYANEMHANDU C, Garvey C, Chin A, Metcalfe J, et al
    More should be done now for patients with TB-associated chronic lung disease.
    Int J Tuberc Lung Dis. 2019;23:1122-1123.
    PubMed    


  243. JINDAL SK
    Searching for a mole in the hill.
    Int J Tuberc Lung Dis. 2019;23:1047.
    PubMed    


    September 2019
  244. VANINO E, Tadolini M, Attard L, Cascavilla A, et al
    A multidrug resistant tuberculosis case treated with continuous infusion of meropenem in outpatient care.
    Int J Tuberc Lung Dis. 2019;23:1042.
    PubMed    


  245. GALEGO MA, Santos JV, Viana J, Freitas A, et al
    To be or not to be hospitalised with tuberculosis in Portugal.
    Int J Tuberc Lung Dis. 2019;23:1029-1034.
    PubMed     Abstract available


  246. DI BELLA S, Siroka A, Antonello RM, Zignol M, et al
    Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country.
    Int J Tuberc Lung Dis. 2019;23:1024-1028.
    PubMed     Abstract available


  247. HUGHES J, Reuter A, Chabalala B, Isaakidis P, et al
    Adverse events among people on delamanid for rifampicin-resistant tuberculosis in a high HIV prevalence setting.
    Int J Tuberc Lung Dis. 2019;23:1017-1023.
    PubMed     Abstract available


  248. PEREA-JACOBO R, Muniz-Salazar R, Laniado-Laborin R, Cabello-Pasini A, et al
    Rifampin pharmacokinetics in tuberculosis-diabetes mellitus patients: a pilot study from Baja California, Mexico.
    Int J Tuberc Lung Dis. 2019;23:1012-1016.
    PubMed     Abstract available


  249. BUZIASHVILI M, Mirtskhulava V, Kipiani M, Blumberg HM, et al
    Rates and risk factors for nephrotoxicity and ototoxicity among tuberculosis patients in Tbilisi, Georgia.
    Int J Tuberc Lung Dis. 2019;23:1005-1011.
    PubMed     Abstract available


  250. OTA M, Uchimura K
    Trends of tuberculosis rates before and after the declaration as a public health emergency in Japan, 1992-2006.
    Int J Tuberc Lung Dis. 2019;23:1000-1004.
    PubMed     Abstract available


  251. HELD K, McAnaw S, Chiang CY, Trebucq A, et al
    Progress in global rollout of new multidrug-resistant tuberculosis treatments.
    Int J Tuberc Lung Dis. 2019;23:996-999.
    PubMed     Abstract available


  252. ZHANG HC, Ruan QL, Wu J, Zhang S, et al
    Serial T-SPOT.TB in household contacts of tuberculosis patients: a 6-year observational study in China.
    Int J Tuberc Lung Dis. 2019;23:989-995.
    PubMed     Abstract available


  253. FARLEY JE, McKenzie-White J, Bollinger R, Hong H, et al
    Evaluation of miLINC to shorten time to treatment for rifampicin-resistant Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:980-988.
    PubMed     Abstract available


  254. SMITTIPAT N, Miyahara R, Juthayothin T, Billamas P, et al
    Indo-Oceanic Mycobacterium tuberculosis strains from Thailand associated with higher mortality.
    Int J Tuberc Lung Dis. 2019;23:972-979.
    PubMed     Abstract available


  255. MISHRA B, Mohapatra PR
    Expand the RRDR hotspot to improve GeneXpert results.
    Int J Tuberc Lung Dis. 2019;23:1043.
    PubMed    


  256. HARRIES AD, Chakaya JM
    Assessing and managing pulmonary impairment in those who have completed TB treatment in programmatic settings.
    Int J Tuberc Lung Dis. 2019;23:1044-1045.
    PubMed    


  257. HARRIES AD, Timire C, Takarinda KC, Sandy C, et al
    Ensuring that Xpert((R)) MTB/RIF is used to its maximum potential.
    Int J Tuberc Lung Dis. 2019;23:1043-1044.
    PubMed    


    August 2019
  258. FRANKE MF, Rodriguez CA, Mitnick CD
    Causal inference in tuberculosis treatment studies: bias considerations and data needs.
    Int J Tuberc Lung Dis. 2019;23:960-961.
    PubMed    


  259. FURIN J, Frick M, McKenna L
    A human rights-based approach to tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2019;23:959.
    PubMed    


  260. VAN DEUN A, Tahseen S, Affolabi D, Hossain MA, et al
    In reply: A human rights-based approach to tuberculosis diagnosis.
    Int J Tuberc Lung Dis. 2019;23:959-960.
    PubMed    


  261. SONG HJ, Park H, Seo HJ
    Association between use of proton pump inhibitors and tuberculosis risk: a systematic review.
    Int J Tuberc Lung Dis. 2019;23:943-951.
    PubMed     Abstract available


  262. SUN Y, Gao L, Xia H, Yang Z, et al
    Accuracy of molecular diagnostic tests for drug-resistant tuberculosis detection in China: a systematic review.
    Int J Tuberc Lung Dis. 2019;23:931-942.
    PubMed     Abstract available


  263. PARK S, Yang BR, Song HJ, Jang SH, et al
    Metformin and tuberculosis risk in elderly patients with diabetes mellitus.
    Int J Tuberc Lung Dis. 2019;23:924-930.
    PubMed     Abstract available


  264. GURJAV U, Ankhbat M, Ganbaatar G, Batjarga K, et al
    Vitamin D deficiency is associated with tuberculosis infection among household contacts in Ulaanbaatar, Mongolia.
    Int J Tuberc Lung Dis. 2019;23:919-923.
    PubMed     Abstract available


  265. TAHSEEN S, Ambreen A, Masood F, Qadir M, et al
    Primary drug resistance in extra-pulmonary tuberculosis: a hospital-based prospective study from Pakistan.
    Int J Tuberc Lung Dis. 2019;23:900-906.
    PubMed     Abstract available


  266. MARX FM, Cohen T, Lombard C, Hesseling AC, et al
    Notification of relapse and other previously treated tuberculosis in the 52 health districts of South Africa.
    Int J Tuberc Lung Dis. 2019;23:891-899.
    PubMed     Abstract available


  267. KRAKAUER EL, Dheda K, Kalsdorf B, Kuksa L, et al
    Palliative care and symptom relief for people affected by multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:881-890.
    PubMed     Abstract available


  268. CHESOV D, Lange C, Heyckendorf J
    Molecular-based tuberculosis drug susceptibility testing: one size fits all?
    Int J Tuberc Lung Dis. 2019;23:879-880.
    PubMed    


    July 2019
  269. MORASERT T
    In reply to Comments on "Prevalence and risk factors associated with tuberculosis disease in Suratthani Central Prison, Thailand".
    Int J Tuberc Lung Dis. 2019;23:874-875.
    PubMed    


  270. COX SN, Elf JL, Lokhande R, Ogale YP, et al
    Mobile phone access and comfort: implications for HIV and tuberculosis care in India and South Africa.
    Int J Tuberc Lung Dis. 2019;23:865-872.
    PubMed     Abstract available


  271. RUSWA N, Mavhunga F, Roscoe JC, Beukes A, et al
    Second nationwide anti-tuberculosis drug resistance survey in Namibia.
    Int J Tuberc Lung Dis. 2019;23:858-864.
    PubMed     Abstract available


  272. LEE M, Han J, Kim YR, Kwak N, et al
    Multidrug-resistant tuberculosis in South Korea: a retrospective analysis of national registry data in 2011-2015.
    Int J Tuberc Lung Dis. 2019;23:850-857.
    PubMed     Abstract available


  273. YUEN CM, Agaya J, Mchembere W, Okelloh D, et al
    Optimizing the efficiency of tuberculosis active case-finding in health facilities and communities.
    Int J Tuberc Lung Dis. 2019;23:844-849.
    PubMed     Abstract available


  274. IRFAN S, Rao N, Irfan M, Iftikhar I, et al
    Utility of the microcolony method for evaluation of multidrug-resistant tuberculosis patients in Karachi, Pakistan.
    Int J Tuberc Lung Dis. 2019;23:838-843.
    PubMed     Abstract available


  275. BOGDANOVA E, Mariandyshev O, Hinderaker SG, Nikishova E, et al
    Mass screening for active case finding of pulmonary tuberculosis in the Russian Federation: how to save costs.
    Int J Tuberc Lung Dis. 2019;23:830-837.
    PubMed     Abstract available


  276. SGRO A, Ots R, Brunetti E
    Impact of World Tuberculosis Day on digital awareness of tuberculosis: analyses using Google Trends.
    Int J Tuberc Lung Dis. 2019;23:824-829.
    PubMed     Abstract available


  277. PHILIPSEN RHHM, Sanchez CI, Melendez J, Lew WJ, et al
    Automated chest X-ray reading for tuberculosis in the Philippines to improve case detection: a cohort study.
    Int J Tuberc Lung Dis. 2019;23:805-810.
    PubMed     Abstract available


  278. ARMSTRONG LR, Winston CA, Stewart B, Tsang CA, et al
    Changes in tuberculosis epidemiology, United States, 1993-2017.
    Int J Tuberc Lung Dis. 2019;23:797-804.
    PubMed     Abstract available


  279. HUANGFU P, Ugarte-Gil C, Golub J, Pearson F, et al
    The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:783-796.
    PubMed     Abstract available


  280. TALBOT EA, Pai M
    Tackling drug-resistant tuberculosis: we need a critical synergy of product and process innovations.
    Int J Tuberc Lung Dis. 2019;23:774-782.
    PubMed     Abstract available


  281. DEDICOAT M
    Tuberculosis control in the United States: strengths, weaknesses, opportunities, threats.
    Int J Tuberc Lung Dis. 2019;23:773.
    PubMed    


  282. LIN Y, Harries AD, Kumar AMV, Critchley JA, et al
    Tackling diabetes mellitus and tuberculosis: a new Union guide on the management of diabetes-tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:771-772.
    PubMed    


  283. MARTINEZ-GIRON R, van Woerden HC
    The recognition of Lophomonas blattarum in fresh respiratory samples in recent correspondence.
    Int J Tuberc Lung Dis. 2019;23:873-874.
    PubMed    


  284. SILVA A, Ponte C, Antas PRZ
    What a difference a strain makes!
    Int J Tuberc Lung Dis. 2019;23:874.
    PubMed    


  285. NDAKIDEMI E, Emerson C, Medley A, Ngowi B, et al
    Health care worker perspectives on TB case finding and HIV services among pediatric TB patients in Tanzania.
    Int J Tuberc Lung Dis. 2019;23:811-816.
    PubMed     Abstract available


    June 2019
  286. DEL CASTILLO HX, Munive RA, Araujo-Castillo RV
    Comments on "Prevalence and risk factors associated with tuberculosis disease in Suratthani Central Prison, Thailand".
    Int J Tuberc Lung Dis. 2019;23:768-769.
    PubMed    


  287. CASTELLANOS ME, Martinez L, Whalen CC
    In reply to 'Interferon-gamma release assays have suboptimal sensitivity in both latent and active tuberculosis'.
    Int J Tuberc Lung Dis. 2019;23:767.
    PubMed    


  288. GOETZINGER F, Burkhardt I, Villanueva P, Clifford V, et al
    Interferon-gamma release assays have suboptimal sensitivity in both latent and active tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:766-767.
    PubMed    


  289. STRACKER N, Hanrahan C, Mmolawa L, Nonyane B, et al
    Risk factors for catastrophic costs associated with tuberculosis in rural South Africa.
    Int J Tuberc Lung Dis. 2019;23:756-763.
    PubMed     Abstract available


  290. VYAS A, Creswell J, Codlin AJ, Stevens R, et al
    Community-based active case-finding to reach the most vulnerable: tuberculosis in tribal areas of India.
    Int J Tuberc Lung Dis. 2019;23:750-755.
    PubMed     Abstract available


  291. TOLA HH, Holakouie-Naieni K, Tesfaye E, Mansournia MA, et al
    Prevalence of tuberculosis treatment non-adherence in Ethiopia: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:741-749.
    PubMed     Abstract available


  292. LI B, Zhang X, Guo J, Wang J, et al
    Prevalence of pulmonary tuberculosis in Tibet Autonomous Region, China, 2014.
    Int J Tuberc Lung Dis. 2019;23:735-740.
    PubMed     Abstract available


  293. PETERSON ML, Gandhi NR, Clennon J, Nelson KN, et al
    Extensively drug-resistant tuberculosis 'hotspots' and sociodemographic associations in Durban, South Africa.
    Int J Tuberc Lung Dis. 2019;23:720-727.
    PubMed     Abstract available


  294. GAUTAM H, Singla M, Jain R, Lodha R, et al
    Point-of-care urine lipoarabinomannan antigen detection for diagnosis of tuberculosis in children.
    Int J Tuberc Lung Dis. 2019;23:714-719.
    PubMed     Abstract available


  295. LALOR MK, Perkins S, Thomas HL
    Burden of multidrug-resistant tuberculosis in England: a focus on prevalent cases.
    Int J Tuberc Lung Dis. 2019;23:707-713.
    PubMed     Abstract available


  296. HAN S, Yoon SH, Goo JM, Yim JJ, et al
    Radiological features and progression of incipient active pulmonary tuberculosis according to risk factors.
    Int J Tuberc Lung Dis. 2019;23:698-706.
    PubMed     Abstract available


  297. HU T, Xu Y, Song Y, Xia X, et al
    Mitochondrial DNA haplogroup C4 can increase the risk of active tuberculosis disease in Southwest China.
    Int J Tuberc Lung Dis. 2019;23:692-697.
    PubMed     Abstract available


  298. JIANG Q, Ji L, Qiu Y, Su X, et al
    A randomised controlled trial of stepwise sputum collection to increase yields of confirmed tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:685-691.
    PubMed     Abstract available


  299. MARTINEZ N, Kornfeld H
    Tuberculosis and diabetes: from bench to bedside and back.
    Int J Tuberc Lung Dis. 2019;23:669-677.
    PubMed     Abstract available


  300. BAO J, Sha W, Zhang WH, Zhang T, et al
    Curbing the diabetes and tuberculosis co-epidemic: the potential role of China.
    Int J Tuberc Lung Dis. 2019;23:663-668.
    PubMed     Abstract available


  301. LANGE C, Aarnoutse RE, Alffenaar JWC, Bothamley G, et al
    Management of patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:645-662.
    PubMed     Abstract available


  302. VAN DEN HOF S
    Hotspots for transmission of extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:643-644.
    PubMed    


  303. DIAS HMY, Stallworthy G, Pai M
    A roadmap to engage all care providers in tuberculosis prevention and care.
    Int J Tuberc Lung Dis. 2019;23:641-642.
    PubMed    


  304. KAMAT AS, Gretschel A, Vlok AJ, Solomons R, et al
    Reply to "Cerebrospinal fluid protein and shunt obstruction in tuberculous meningitis".
    Int J Tuberc Lung Dis. 2019;23:767-768.
    PubMed    


  305. FIGAJI A, Fieggen G, Enslin N, Taylor A, et al
    Cerebrospinal fluid protein and shunt obstruction in tuberculous meningitis.
    Int J Tuberc Lung Dis. 2019;23:765.
    PubMed    


  306. ASSEFA Y, Woldeyohannes S, Gelaw YA, Hamada Y, et al
    Screening tools to exclude active pulmonary TB in high TB burden countries: systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:728-734.
    PubMed     Abstract available


    May 2019
  307. BROZ J, Jarosova B, Salih SFA, Brabec M, et al
    Association between diabetes mellitus and mortality among patients with tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:638.
    PubMed    


  308. NGUYEN CH, Pascopella L, Barry PM
    Response to IJTLD 11-18-0796 correspondence by J Broz, B Jarosova, S F A Salih, M Brabec, F M A Salih related to 'Association between diabetes mellitus and mortality among patients with tuberculosis in California, 2010-2014'.
    Int J Tuberc Lung Dis. 2019;23:638-639.
    PubMed    


  309. SCHWOEBEL V, Chiang CY, Trebucq A, Piubello A, et al
    Outcome definitions for multidrug-resistant tuberculosis treated with shorter treatment regimens.
    Int J Tuberc Lung Dis. 2019;23:619-624.
    PubMed     Abstract available


  310. HELDAL E, Dlodlo RA, Mlilo N, Nyathi BB, et al
    Local staff making sense of their tuberculosis data: key to quality care and ending tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:612-618.
    PubMed     Abstract available


  311. SWEETLAND AC, Galea J, Shin SS, Driver C, et al
    Integrating tuberculosis and mental health services: global receptivity of national tuberculosis program directors.
    Int J Tuberc Lung Dis. 2019;23:600-605.
    PubMed     Abstract available


  312. WHITEHOUSE ER, Perrin N, Levitt N, Hill M, et al
    Cardiovascular risk prevalence in South Africans with drug-resistant tuberculosis: a cross-sectional study.
    Int J Tuberc Lung Dis. 2019;23:587-593.
    PubMed     Abstract available


  313. USEMANN J, Ledergerber M, Fink G, Ritz N, et al
    Cost-effectiveness of tuberculosis screening for migrant children in a low-incidence country.
    Int J Tuberc Lung Dis. 2019;23:579-586.
    PubMed     Abstract available


  314. BUNYASI EW, Geldenhuys H, Mulenga H, Shenje J, et al
    Temporal trends in the prevalence of Mycobacterium tuberculosis infection in South African adolescents.
    Int J Tuberc Lung Dis. 2019;23:571-578.
    PubMed     Abstract available


  315. CHO PJ, Wu CY, Johnston J, Wu MY, et al
    Progression of chronic kidney disease and the risk of tuberculosis: an observational cohort study.
    Int J Tuberc Lung Dis. 2019;23:555-562.
    PubMed     Abstract available


  316. ALLWOOD BW, Rigby J, Griffith-Richards S, Kanarek D, et al
    Histologically confirmed tuberculosis-associated obstructive pulmonary disease.
    Int J Tuberc Lung Dis. 2019;23:552-554.
    PubMed     Abstract available


  317. JARAMILLO J, Yadav R, Herrera R
    Why every word counts: towards patient- and people-centered tuberculosis care.
    Int J Tuberc Lung Dis. 2019;23:547-551.
    PubMed     Abstract available


  318. KENDALL EA, Sahu S, Pai M, Fox GJ, et al
    What will it take to eliminate drug-resistant tuberculosis?
    Int J Tuberc Lung Dis. 2019;23:535-546.
    PubMed     Abstract available


  319. RIDZON R, Castro KG
    A step forward in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:533-534.
    PubMed    


  320. FRANKE MF, Smith S
    Where there's a will, there's a way: advancing integrated care for mental health, substance use and tuberculosis disease.
    Int J Tuberc Lung Dis. 2019;23:529-530.
    PubMed    


  321. MITCHELL EMH, Heumann SG, Sprague L, Tesfaye DH, et al
    'Reservoir of infection' or 'fount of knowledge'? Forging equal partnerships and shifting power to address LTBI.
    Int J Tuberc Lung Dis. 2019;23:527-528.
    PubMed    


  322. HAROUNA SH, Ortuno-Gutierrez N, Souleymane MB, Kizito W, et al
    Short-course treatment outcomes and adverse events in adults and children-adolescents with MDR-TB in Niger.
    Int J Tuberc Lung Dis. 2019;23:625-630.
    PubMed     Abstract available


  323. ISMAIL NA, Said HM, Rodrigues C, Omar SV, et al
    Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testing.
    Int J Tuberc Lung Dis. 2019;23:594-599.
    PubMed     Abstract available


  324. BERROCAL-ALMANZA LC, Botticello J, Piotrowski H, Karnani N, et al
    Engaging with civil society to improve access to LTBI screening for new migrants in England: a qualitative study.
    Int J Tuberc Lung Dis. 2019;23:563-570.
    PubMed     Abstract available


    April 2019
  325. CHESOV D, Alexandru S, Crudu V, Ciobanu N, et al
    Failing treatment of multidrug-resistant tuberculosis: a matter of definition.
    Int J Tuberc Lung Dis. 2019;23:522-524.
    PubMed    


  326. MUSAAZI J, Sekaggya-Wiltshire C, Kiragga AN, Kalule I, et al
    Sustained positive impact on tuberculosis treatment outcomes of TB-HIV integrated care in Uganda.
    Int J Tuberc Lung Dis. 2019;23:514-521.
    PubMed     Abstract available


  327. GOLUB JE, Mok Y, Hong S, Jung KJ, et al
    Diabetes mellitus and tuberculosis in Korean adults: impact on tuberculosis incidence, recurrence and mortality.
    Int J Tuberc Lung Dis. 2019;23:507-513.
    PubMed     Abstract available


  328. KUYINU YA, Goodman OO, Odugbemi BA, Adeyeye OO, et al
    Tuberculosis infection prevention and control measures in DOTS centres in Lagos State, Nigeria.
    Int J Tuberc Lung Dis. 2019;23:474-481.
    PubMed     Abstract available


  329. SORNBOOT J, Aekplakorn W, Ramasoota P, Bualert S, et al
    Detection of airborne Mycobacterium tuberculosis complex in high-risk areas of health care facilities in Thailand.
    Int J Tuberc Lung Dis. 2019;23:465-473.
    PubMed     Abstract available


  330. HOFMANN-THIEL S, Molodtsov N, Duffner C, Kadyrov A, et al
    Capacity of Abbott RealTime MTB RIF/INH to detect rifampicin- and isoniazid-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:458-464.
    PubMed     Abstract available


  331. GUPTE AN, Selvaraju S, Paradkar M, Danasekaran K, et al
    Respiratory health status is associated with treatment outcomes in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:450-457.
    PubMed     Abstract available


  332. KIBUULE D, Rennie TW, Ruswa N, Mavhunga F, et al
    Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia.
    Int J Tuberc Lung Dis. 2019;23:441-449.
    PubMed     Abstract available


  333. KATO-MAEDA M, Choi JC, Jarlsberg LG, Grinsdale JA, et al
    Magnitude of Mycobacterium tuberculosis transmission among household and non-household contacts of TB patients.
    Int J Tuberc Lung Dis. 2019;23:433-440.
    PubMed     Abstract available


  334. LEE S, Lee JE, Kang JS, Lee SO, et al
    Long-term performance of the IGRA to predict and prevent active tuberculosis development in HIV-infected patients.
    Int J Tuberc Lung Dis. 2019;23:422-427.
    PubMed     Abstract available


  335. SILVA DS, Komparic A, Upshur REG, Gibson J, et al
    Provider perspectives on liberty and harm in the treatment of persons with tuberculosis and mental illness.
    Int J Tuberc Lung Dis. 2019;23:405-411.
    PubMed     Abstract available


  336. NATHAVITHARANA RR, Lederer P, Tierney DB, Nardell E, et al
    Treatment as prevention and other interventions to reduce transmission of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:396-404.
    PubMed     Abstract available


  337. CASTRO KG
    Overcoming prevailing neglect to prevent transmission of Mycobacterium tuberculosis infection in health care facilities.
    Int J Tuberc Lung Dis. 2019;23:383-384.
    PubMed    


  338. MENZIES NA, McQuaid CF, Gomez GB, Siroka A, et al
    Improving the quality of modelling evidence used for tuberculosis policy evaluation.
    Int J Tuberc Lung Dis. 2019;23:387-395.
    PubMed     Abstract available


  339. FANNING A
    Community-based directly observed therapy improves treatment success.
    Int J Tuberc Lung Dis. 2019;23:381-382.
    PubMed    


  340. KYI MS, Aung ST, Oo HN, Chongsuvivatwong V, et al
    Fully vs. partially integrated services for TB-HIV in Myanmar: a health services review and a cohort study.
    Int J Tuberc Lung Dis. 2019;23:498-506.
    PubMed     Abstract available


  341. EPSTEIN RL, Bhagavathula M, Saag LA, Verma S, et al
    QuantiFERON((R))-TB Gold In-Tube reliability for immigrants with parasitic infections in Boston, USA.
    Int J Tuberc Lung Dis. 2019;23:482-490.
    PubMed     Abstract available


    March 2019
  342. TESEMA E, Wares F, Bedru A, Negeri C, et al
    Hear this! Audiometry testing saves the hearing of a patient with drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:378-379.
    PubMed    


  343. SIFUNA PM, Ouma C, Atieli H, Owuoth J, et al
    Spatial epidemiology of tuberculosis in the high-burden counties of Kisumu and Siaya, Western Kenya, 2012-2015.
    Int J Tuberc Lung Dis. 2019;23:363-370.
    PubMed     Abstract available


  344. PHYO KH, Oo MM, Harries AD, Saw S, et al
    High prevalence and incidence of tuberculosis in people living with the HIV in Mandalay, Myanmar, 2011-2017.
    Int J Tuberc Lung Dis. 2019;23:349-357.
    PubMed     Abstract available


  345. WINGFIELD T, MacPherson P, Sodha P, Tucker A, et al
    Contacts of underserved tuberculosis patients have higher odds of TB disease in North West England: a cohort study.
    Int J Tuberc Lung Dis. 2019;23:337-343.
    PubMed     Abstract available


  346. MAKHMUDOVA M, Maxsumova Z, Rajabzoda A, Makhmadov A, et al
    Risk factors for unfavourable treatment outcomes among rifampicin-resistant tuberculosis patients in Tajikistan.
    Int J Tuberc Lung Dis. 2019;23:331-336.
    PubMed     Abstract available


  347. LO TQ, Matlhare L, Mugisha K, Lere TD, et al
    Initiation of anti-tuberculosis treatment in children following gastric aspirate testing, Botswana, 2008-2012.
    Int J Tuberc Lung Dis. 2019;23:315-321.
    PubMed     Abstract available


  348. CRABTREE-RAMIREZ B, Jenkins C, Jayathilake K, Carriquiry G, et al
    HIV-related tuberculosis: mortality risk in persons without vs. with culture-confirmed disease.
    Int J Tuberc Lung Dis. 2019;23:306-314.
    PubMed     Abstract available


  349. RICHARDSON M, Kirkham J, Dwan K, Sloan DJ, et al
    NAT2 variants and toxicity related to anti-tuberculosis agents: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:293-305.
    PubMed     Abstract available


  350. HUANGFU P, Laurence YV, Alisjahbana B, Ugarte-Gil C, et al
    Point of care HbA1c level for diabetes mellitus management and its accuracy among tuberculosis patients: a study in four countries.
    Int J Tuberc Lung Dis. 2019;23:283-292.
    PubMed     Abstract available


  351. MACIAS CP, Monedero-Recuero I
    TB or not TB? Challenges in diagnosing and treating maternal and neonatal tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:280-282.
    PubMed     Abstract available


  352. NGUENHA D, Garcia JI, Cowan JF, Garcia-Basteiro AL, et al
    Spatial epidemiology for tuberculosis surveillance: a relevant add-on to routine surveillance.
    Int J Tuberc Lung Dis. 2019;23:278-279.
    PubMed    


  353. SANTOS AP, Migliori GB
    Another aetiology for tuberculosis-beyond the Mycobacterium.
    Int J Tuberc Lung Dis. 2019;23:277.
    PubMed    


  354. KWON YS, Koh WJ
    The mortality rates for tuberculosis remain high even in high-income countries.
    Int J Tuberc Lung Dis. 2019;23:275-276.
    PubMed    


  355. BERHANU RH, Schnippel K, Kularatne R, Firnhaber C, et al
    Discordant rifampicin susceptibility results are associated with Xpert((R)) MTB/RIF probe B and probe binding delay.
    Int J Tuberc Lung Dis. 2019;23:358-362.
    PubMed     Abstract available


  356. LAI J, Dememew Z, Jerene D, Abashawl A, et al
    Provider barriers to the uptake of isoniazid preventive therapy among people living with HIV in Ethiopia.
    Int J Tuberc Lung Dis. 2019;23:371-377.
    PubMed     Abstract available


  357. KURTZ T, Feil AC, Nascimento LS, de Oliveira Abreu P, et al
    Effect of neonatal bacille Calmette-Guerin on the tuberculin skin test reaction in the first 2 years of life.
    Int J Tuberc Lung Dis. 2019;23:344-348.
    PubMed     Abstract available


  358. KYAW NTT, Kumar AMV, Kyaw KWY, Satyanarayana S, et al
    IPT in people living with HIV in Myanmar: a five-fold decrease in incidence of TB disease and all-cause mortality.
    Int J Tuberc Lung Dis. 2019;23:322-330.
    PubMed     Abstract available


    February 2019
  359. ZHANG RR, Liang L, Chen WW, Wen C, et al
    ULK1 polymorphisms confer susceptibility to pulmonary tuberculosis in a Chinese population.
    Int J Tuberc Lung Dis. 2019;23:265-271.
    PubMed     Abstract available


  360. MAZZARELLI A, Cannas A, Venditti C, D'Arezzo S, et al
    Clinical evaluation of TRCReady M.TB for rapid automated detection of M. tuberculosis complex in respiratory samples.
    Int J Tuberc Lung Dis. 2019;23:260-264.
    PubMed     Abstract available


  361. HOOD G, Trieu L, Ahuja SD
    Mortality among tuberculosis patients in New York City.
    Int J Tuberc Lung Dis. 2019;23:252-259.
    PubMed     Abstract available


  362. HARRIES AD, Schwoebel V, Monedero-Recuero I, Aung TK, et al
    Challenges and opportunities to prevent tuberculosis in people living with HIV in low-income countries.
    Int J Tuberc Lung Dis. 2019;23:241-251.
    PubMed     Abstract available


  363. GOLLI AL, Nitu MF, Turcu F, Popescu M, et al
    Tuberculosis remains a public health problem in Romania.
    Int J Tuberc Lung Dis. 2019;23:226-231.
    PubMed     Abstract available


  364. LUO J, Luo M, Li J, Yu J, et al
    Rapid direct drug susceptibility testing of Mycobacterium tuberculosis based on culture droplet digital polymerase chain reaction.
    Int J Tuberc Lung Dis. 2019;23:219-225.
    PubMed     Abstract available


  365. COELHO DA SILVA FD, Covre LP, Stringari LL, Palaci M, et al
    Toll-like receptors blocking restores in vitro microbicidal activity in latent tuberculosis-infected subjects.
    Int J Tuberc Lung Dis. 2019;23:212-218.
    PubMed     Abstract available


  366. CHIN AT, Rylance J, Makumbirofa S, Meffert S, et al
    Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study.
    Int J Tuberc Lung Dis. 2019;23:203-211.
    PubMed     Abstract available


  367. FIOGBE AA, Agodokpessi G, Tessier JF, Affolabi D, et al
    Prevalence of lung function impairment in cured pulmonary tuberculosis patients in Cotonou, Benin.
    Int J Tuberc Lung Dis. 2019;23:195-202.
    PubMed     Abstract available


  368. ENDALAMAW A, Ambachew S, Geremew D, Habtewold TD, et al
    HIV infection and unknown HIV status among tuberculosis patients in Ethiopia: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:187-194.
    PubMed     Abstract available


  369. MURAKAMI R, Matsuo N, Ueda K, Nakazawa M, et al
    Epidemiological and spatial factors for tuberculosis: a matched case-control study in Nagata, Japan.
    Int J Tuberc Lung Dis. 2019;23:181-186.
    PubMed     Abstract available


  370. KWAK N, Kim HR, Yoo CG, Kim YW, et al
    Multidrug-resistant tuberculosis over 20 years at a referral hospital in South Korea: trends and outcomes.
    Int J Tuberc Lung Dis. 2019;23:174-180.
    PubMed     Abstract available


  371. ZURITA J, Espinel N, Barba P, Ortega-Paredes D, et al
    Genetic diversity and drug resistance of Mycobacterium tuberculosis in Ecuador.
    Int J Tuberc Lung Dis. 2019;23:166-173.
    PubMed     Abstract available


  372. COX V, Cox H, Pai M, Stillo J, et al
    Health care gaps in the global burden of drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:125-135.
    PubMed     Abstract available


  373. SULEIMAN K, England K, Lessem E, McKenna L, et al
    Key features to consider in revising the Model List of Essential In Vitro Diagnostics: a TB perspective.
    Int J Tuberc Lung Dis. 2019;23:272.
    PubMed    


  374. SYKES CA, Shepherd J, McGoldrick C, Kennedy N, et al
    A case of rifampicin-induced haemolysis.
    Int J Tuberc Lung Dis. 2019;23:239-240.
    PubMed     Abstract available


  375. VAN AERDE KJ, van der Heijden EHFM, Henriet SS, Merkus PJ, et al
    A case promoting use of ultrasound-guided sampling techniques to correctly diagnose MDR-TB in children.
    Int J Tuberc Lung Dis. 2019;23:236-238.
    PubMed     Abstract available


  376. RENDON A, Silva DR, Esposito S, Sotgiu G, et al
    Launching the Global TB Network.
    Int J Tuberc Lung Dis. 2019;23:123-124.
    PubMed    


    January 2019
  377. PALEIRON N, Soler C, Hassan MO, Andriamanantena D, et al
    First description of Mycobacterium tuberculosis and M. canettii concomitant infection: report of two cases.
    Int J Tuberc Lung Dis. 2019 Jan 24. doi: 10.5588/ijtld.18.0261.
    PubMed     Abstract available


  378. HANIFA Y, Toro Silva S, Karstaedt A, Sahid F, et al
    What causes symptoms suggestive of tuberculosis in HIV-positive people with negative initial investigations?
    Int J Tuberc Lung Dis. 2019 Jan 24. doi: 10.5588/ijtld.18.0251.
    PubMed     Abstract available


  379. MOK J, Kang BH, Kim HJ, Lee SJ, et al
    Drug resistance in extra-pulmonary tuberculosis in South Korea: comparison with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0109.
    PubMed     Abstract available


  380. LE H, Nguyen N, Tran P, Hoa N, et al
    Process measure of FAST tuberculosis infection control demonstrates delay in likely effective treatment.
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0268.
    PubMed     Abstract available


  381. YE R, Wang C, Zhao L, Wu X, et al
    Characteristics of miliary tuberculosis in pregnant women after in vitro fertilisation and embryo transfer.
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0223.
    PubMed     Abstract available


  382. BHARGAVA M, Bhargava A, Akshaya KM, Shastri SG, et al
    Nutritional assessment and counselling of tuberculosis patients at primary care in India: do we measure up?
    Int J Tuberc Lung Dis. 2019 Jan 8. doi: 10.5588/ijtld.18.0333.
    PubMed     Abstract available


  383. ANAGNOSTOPOULOS I, Lagou S, Papatheodoridi M, Marinos L, et al
    A rare case of bone marrow BCG-itis responding to second-line anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2019;23:119-120.
    PubMed    


  384. RAHU K, Viiklepp P, Villand K, Pehme L, et al
    Respiratory tuberculosis incidence and mortality in Estonia: 30-year trends and sociodemographic determinants.
    Int J Tuberc Lung Dis. 2019;23:112-118.
    PubMed     Abstract available


  385. YASSEEN AS, Rea E, Hirji MM, Yang C, et al
    Paediatric tuberculosis among the foreign-born: utility of the Canadian TB immigration medical surveillance programme.
    Int J Tuberc Lung Dis. 2019;23:105-111.
    PubMed     Abstract available


  386. PERRINEAU S, Lachatre M, Le MP, Rioux C, et al
    Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:99-104.
    PubMed     Abstract available


  387. LAXMESHWAR C, Stewart AG, Dalal A, Kumar AMV, et al
    Beyond 'cure' and 'treatment success': quality of life of patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2019;23:73-81.
    PubMed     Abstract available


  388. AZNAR ML, Rando-Segura A, Moreno MM, Soley ME, et al
    Prevalence and risk factors of multidrug-resistant tuberculosis in Cubal, Angola: a prospective cohort study.
    Int J Tuberc Lung Dis. 2019;23:67-72.
    PubMed     Abstract available


  389. ALEXANDER M, Gupta A, Mathad JS
    Is there a connection between gestational diabetes mellitus, human immunodeficiency virus infection, and tuberculosis?
    Int J Tuberc Lung Dis. 2019;23:19-25.
    PubMed     Abstract available


  390. DOWDY DW
    Xpert at 8 years: where are we now, and what should we do next?
    Int J Tuberc Lung Dis. 2019;23:3-4.
    PubMed    


  391. POTTER JL, White VLC
    Patients want to live, not merely survive.
    Int J Tuberc Lung Dis. 2019;23:1-2.
    PubMed    


  392. REIMANN M, Schaub D, Kalsdorf B, Runge C, et al
    Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB.
    Int J Tuberc Lung Dis. 2019;23:93-98.
    PubMed     Abstract available


  393. AGIZEW T, Boyd R, Auld AF, Payton L, et al
    Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2019;23:82-92.
    PubMed     Abstract available


  394. PEDRAZZOLI D, Borghi J, Viney K, Houben RMGJ, et al
    Measuring the economic burden for TB patients in the End TB Strategy and Universal Health Coverage frameworks.
    Int J Tuberc Lung Dis. 2019;23:5-11.
    PubMed     Abstract available


  395. AGGERBECK H, Ruhwald M, Hoff ST, Tingskov PN, et al
    Interaction between C-Tb and PPD given concomitantly in a split-body randomised controlled trial.
    Int J Tuberc Lung Dis. 2019;23:38-44.
    PubMed     Abstract available


  396. VAN DEUN A, Tahseen S, Affolabi D, Hossain MA, et al
    Sputum smear microscopy in the Xpert((R)) MTB/RIF era.
    Int J Tuberc Lung Dis. 2019;23:12-18.
    PubMed     Abstract available


    December 2018
  397. SHAH I, Jadhao N, Mali N, Deshpande S, et al
    Pharmacokinetics of isoniazid in Indian children with tuberculosis on daily treatment.
    Int J Tuberc Lung Dis. 2018 Dec 20. doi: 10.5588/ijtld.18.0463.
    PubMed     Abstract available


  398. PRATS-URIBE A, Orcau A, Millet JP, Cayla JA, et al
    Impact of socio-economic inequities on tuberculosis in a Southern European city: What is the effect of the recession?
    Int J Tuberc Lung Dis. 2018 Dec 20. doi: 10.5588/ijtld.18.0110.
    PubMed     Abstract available


  399. YU S, Shen J, Lao S, Yang B, et al
    Distinct functions of CXCR3(+) and CCR4(+)CD4(+) T-cells accumulated in human tuberculosis pleural fluid.
    Int J Tuberc Lung Dis. 2018;22:1514-1522.
    PubMed     Abstract available


  400. ASLAM MV, Owusu-Edusei K, Marks SM, Asay GRB, et al
    Number and cost of hospitalizations with principal and secondary diagnoses of tuberculosis, United States.
    Int J Tuberc Lung Dis. 2018;22:1495-1504.
    PubMed     Abstract available


  401. CHUA AP, Lim LK, Gan SH, Chee CB, et al
    The role of chronic viral hepatitis on tuberculosis treatment interruption.
    Int J Tuberc Lung Dis. 2018;22:1486-1494.
    PubMed     Abstract available


  402. PHO Y, Nhem S, Sok C, By B, et al
    Melioidosis in patients with suspected tuberculosis in Cambodia: a single-center cross-sectional study.
    Int J Tuberc Lung Dis. 2018;22:1481-1485.
    PubMed     Abstract available


  403. ZAWEDDE-MUYANJA S, Manabe YC, Sewankambo NK, Nakiyingi L, et al
    Xpert((R)) MTB/RIF associated with improved treatment initiation among patients with smear-negative tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1475-1480.
    PubMed     Abstract available


  404. NKURUNZIZA J, Karstaedt AS, Louw R, Padanilam X, et al
    Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
    Int J Tuberc Lung Dis. 2018;22:1469-1474.
    PubMed     Abstract available


  405. GE E, Li D, Luo M, Tsui KWS, et al
    Transmission of multidrug-resistant tuberculosis in Shanghai: roles of residential status.
    Int J Tuberc Lung Dis. 2018;22:1462-1468.
    PubMed     Abstract available


  406. OPOLLO VS, Wu X, Hughes MD, Swindells S, et al
    HIV testing uptake among the household contacts of multidrug-resistant tuberculosis index cases in eight countries.
    Int J Tuberc Lung Dis. 2018;22:1443-1449.
    PubMed     Abstract available


  407. HAMADA Y, Ford N, Schenkel K, Getahun H, et al
    Three-month weekly rifapentine plus isoniazid for tuberculosis preventive treatment: a systematic review.
    Int J Tuberc Lung Dis. 2018;22:1422-1428.
    PubMed     Abstract available


  408. VAN CREVEL R, Koesoemadinata R, Hill PC, Harries AD, et al
    Clinical management of combined tuberculosis and diabetes.
    Int J Tuberc Lung Dis. 2018;22:1404-1410.
    PubMed     Abstract available


  409. MENZIES NA, Hill AN, Cohen T, Salomon JA, et al
    The impact of migration on tuberculosis in the United States.
    Int J Tuberc Lung Dis. 2018;22:1392-1403.
    PubMed     Abstract available


  410. AUER C, Bosch-Capblanch X
    Taking tuberculosis seriously requires that we take poverty seriously: reinstating the ethics of public health.
    Int J Tuberc Lung Dis. 2018;22:1390-1391.
    PubMed    


  411. CHAKAYA J, Castro JL, Jensen PM, Fujiwara PI, et al
    A new era for global tuberculosis: holding leaders accountable for promises.
    Int J Tuberc Lung Dis. 2018;22:1387.
    PubMed    


    November 2018
  412. WELLS WA, Stallworthy G, Balsara Z
    How tuberculosis programs can navigate the world of social health insurance.
    Int J Tuberc Lung Dis. 2018 Nov 13. doi: 10.5588/ijtld.18.0289.
    PubMed     Abstract available


  413. SHAW JA, Smit DP, Griffith-Richards S, Koegelenberg CFN, et al
    Utility of routine chest radiography in ocular tuberculosis and sarcoidosis.
    Int J Tuberc Lung Dis. 2018;22:1374-1377.
    PubMed     Abstract available


  414. OBREGON G, Zevallos K, Alarcon V, Puyen ZM, et al
    Rapid drug susceptibility testing and treatment outcomes for multidrug-resistant tuberculosis in Peru.
    Int J Tuberc Lung Dis. 2018;22:1350-1357.
    PubMed     Abstract available


  415. SAWRY S, Moultrie H, Van Rie A
    Evaluation of the intensified tuberculosis case finding guidelines for children living with HIV.
    Int J Tuberc Lung Dis. 2018;22:1322-1328.
    PubMed     Abstract available


  416. ZAWEDDE-MUYANJA S, Nakanwagi A, Dongo JP, Sekadde MP, et al
    Decentralisation of child tuberculosis services increases case finding and uptake of preventive therapy in Uganda.
    Int J Tuberc Lung Dis. 2018;22:1314-1321.
    PubMed     Abstract available


  417. VILLARREAL J, Alarcon V, Alarcon-Arrascue E, Moore DAJ, et al
    Tuberculosis in children treated with second-line drugs under programmatic conditions in Lima, Peru.
    Int J Tuberc Lung Dis. 2018;22:1307-1313.
    PubMed     Abstract available


  418. DE SOUZA RA, Nery JS, Rasella D, Guimaraes Pereira RA, et al
    Family health and conditional cash transfer in Brazil and its effect on tuberculosis mortality.
    Int J Tuberc Lung Dis. 2018;22:1300-1306.
    PubMed     Abstract available


  419. GIL N, Lopez L, Rodriguez D, Rondon M, et al
    Myths and realities about knowledge, attitudes and practices of household contacts of tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1293-1299.
    PubMed     Abstract available


  420. GRACIAA DS, Machaidze M, Kipiani M, Buziashvili M, et al
    A survey of the tuberculosis physician workforce in the country of Georgia.
    Int J Tuberc Lung Dis. 2018;22:1286-1292.
    PubMed     Abstract available


  421. SIMOU E, Britton J, Leonardi-Bee J
    Alcohol consumption and risk of tuberculosis: a systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2018;22:1277-1285.
    PubMed     Abstract available


  422. NGUYEN CH, Pascopella L, Barry PM
    Association between diabetes mellitus and mortality among patients with tuberculosis in California, 2010-2014.
    Int J Tuberc Lung Dis. 2018;22:1269-1276.
    PubMed     Abstract available


  423. MAGEE MJ, Salindri AD, Gujral UP, Auld SC, et al
    Convergence of non-communicable diseases and tuberculosis: a two-way street?
    Int J Tuberc Lung Dis. 2018;22:1258-1268.
    PubMed     Abstract available


  424. JAY SJ, Kirbiyik U, Woods JR, Steele GA, et al
    Modern theory of tuberculosis: culturomic analysis of its historical origin in Europe and North America.
    Int J Tuberc Lung Dis. 2018;22:1249-1257.
    PubMed     Abstract available


    October 2018
  425. MONEDERO-RECUERO I, Hernando-Marrupe L, Sanchez-Montalva A, Cox V, et al
    QTc and anti-tuberculosis drugs: a perfect storm or a tempest in a teacup? Review of evidence and a risk assessment.
    Int J Tuberc Lung Dis. 2018 Oct 26. doi: 10.5588/ijtld.18.0423.
    PubMed     Abstract available


  426. COMSTOCK D, Khorolsky C, Galbraith R
    Severe rifamycin-induced immune thrombocytopenia in a patient with extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1243-1244.
    PubMed    


  427. SETO J, Wada T, Suzuki Y, Ikeda T, et al
    A case of laboratory cross-contamination of Mycobacterium tuberculosis identified using comparative genomics.
    Int J Tuberc Lung Dis. 2018;22:1239-1242.
    PubMed     Abstract available


  428. WANG Y, Wang L, Wen Z, Wang J, et al
    High IL-6 and VEGF-A levels correlate with delayed wound healing in cervical lymph node tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1227-1232.
    PubMed     Abstract available


  429. ALARCON V, Alarcon-Arrascue E, Mendoza-Ticona A, Obregon G, et al
    Programmatic management of patients with pre-extensively drug-resistant tuberculosis in Peru, 2011-2014.
    Int J Tuberc Lung Dis. 2018;22:1220-1226.
    PubMed     Abstract available


  430. RIBEIRO L, Gomes M, Gaio R, Duarte R, et al
    HIV screening of tuberculosis patients in Portugal: what are we missing?
    Int J Tuberc Lung Dis. 2018;22:1216-1219.
    PubMed     Abstract available


  431. MEKONNEN A, Collins JM, Aseffa A, Ameni G, et al
    Prevalence of pulmonary tuberculosis among students in three eastern Ethiopian universities.
    Int J Tuberc Lung Dis. 2018;22:1210-1215.
    PubMed     Abstract available


  432. MORASERT T, Worapas W, Kaewmahit R, Uphala W, et al
    Prevalence and risk factors associated with tuberculosis disease in Suratthani Central Prison, Thailand.
    Int J Tuberc Lung Dis. 2018;22:1203-1209.
    PubMed     Abstract available


  433. KIZITO S, Katamba A, Marquez C, Turimumahoro P, et al
    Quality of care in childhood tuberculosis diagnosis at primary care clinics in Kampala, Uganda.
    Int J Tuberc Lung Dis. 2018;22:1196-1202.
    PubMed     Abstract available


  434. BELGAUMKAR V, Chandanwale A, Valvi C, Pardeshi G, et al
    Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1179-1187.
    PubMed     Abstract available


  435. SILVEIRA MBV, Ferrarini MAG, Viana PO, Succi RC, et al
    Contribution of the interferon-gamma release assay to tuberculosis diagnosis in children and adolescents.
    Int J Tuberc Lung Dis. 2018;22:1172-1178.
    PubMed     Abstract available


  436. PELISSARI DM, Kuhleis DC, Bartholomay P, Barreira D, et al
    Prevalence and screening of active tuberculosis in a prison in the South of Brazil.
    Int J Tuberc Lung Dis. 2018;22:1166-1171.
    PubMed     Abstract available


  437. ARMSTRONG-HOUGH M, Ggita J, Turimumahoro P, Meyer AJ, et al
    'Something so hard': a mixed-methods study of home sputum collection for tuberculosis contact investigation in Uganda.
    Int J Tuberc Lung Dis. 2018;22:1152-1159.
    PubMed     Abstract available


  438. KHAING PS, Kyaw NTT, Satyanarayana S, Oo NL, et al
    Treatment outcome of tuberculosis patients detected using accelerated vs. passive case finding in Myanmar.
    Int J Tuberc Lung Dis. 2018;22:1145-1151.
    PubMed     Abstract available


  439. HAMILTON K, Tolfree R, Mytton J
    A systematic review of active case-finding strategies for tuberculosis in homeless populations.
    Int J Tuberc Lung Dis. 2018;22:1135-1144.
    PubMed     Abstract available


  440. COHEN DB, Meghji J, Squire SB
    A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1127-1134.
    PubMed     Abstract available


  441. HARRIES AD, Lin Y, Kumar AMV, Satyanarayana S, et al
    How can integrated care and research assist in achieving the SDG targets for diabetes, tuberculosis and HIV/AIDS?
    Int J Tuberc Lung Dis. 2018;22:1117-1126.
    PubMed     Abstract available


  442. PARK J, Yim JJ
    Diagnosis of tuberculosis among children: leave no stone unturned.
    Int J Tuberc Lung Dis. 2018;22:1116.
    PubMed    


  443. AULD SC, Gandhi NR, Shah NS
    Closing the book on Category II: time for individualized regimens for patients with recurrent tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1113-1114.
    PubMed    


  444. BAO J, Hafner R, Lin Y, Lin HH, et al
    Curbing the tuberculosis and diabetes co-epidemic: strategies for the integration of clinical care and research.
    Int J Tuberc Lung Dis. 2018;22:1111-1112.
    PubMed    


    September 2018
  445. FOSTER J, McBryde E, Taune M, Peniyamina D, et al
    Cross-border tuberculosis: opportunities, challenges and change.
    Int J Tuberc Lung Dis. 2018;22:1107-1108.
    PubMed    


  446. BARRETO JN, de Lourdes Monteiro M, da Luz Lima M, Valadas E, et al
    Under-reporting of tuberculosis in Praia, Cape Verde: study reports doubtful results.
    Int J Tuberc Lung Dis. 2018;22:1106.
    PubMed    


  447. KOESOEMADINATA RC, Kranzer K, Livia R, Susilawati N, et al
    Computer-assisted chest radiography reading for tuberculosis screening in people living with diabetes mellitus.
    Int J Tuberc Lung Dis. 2018;22:1088-1094.
    PubMed     Abstract available


  448. RAGHUVANSHI S, Kotwal A, Maheshwari R, Sindhwani G, et al
    Evaluation of line-probe assay for molecular analysis and drug susceptibility of extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1077-1081.
    PubMed     Abstract available


  449. GASPAR PC, Rudolf-Oliveira RCM, Wildner LM, de Moraes ACR, et al
    Evaluation of leucocytes from sputum samples of pulmonary tuberculosis patients using flow cytometry.
    Int J Tuberc Lung Dis. 2018;22:1071-1076.
    PubMed     Abstract available


  450. TAKENAMI I, de Oliveira CC, Petrilli JD, Machado A, et al
    Serum antiphospholipid antibody levels as biomarkers for diagnosis of pulmonary tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:1063-1070.
    PubMed     Abstract available


  451. MYO K, Zaw M, Swe TL, Kyaw YY, et al
    Evaluation of Xpert((R)) MTB/RIF assay as a diagnostic test for pulmonary tuberculosis in children in Myanmar.
    Int J Tuberc Lung Dis. 2018;22:1051-1055.
    PubMed     Abstract available


  452. HO-FOSTER A, Tenforde MW, Arscott-Mills T, Maramba M, et al
    Risk factors for gastric aspirate culture contamination in children evaluated for tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2018;22:1044-1050.
    PubMed     Abstract available


  453. DU PREEZ K, du Plessis L, O'Connell N, Hesseling AC, et al
    Burden, spectrum and outcomes of children with tuberculosis diagnosed at a district-level hospital in South Africa.
    Int J Tuberc Lung Dis. 2018;22:1037-1043.
    PubMed     Abstract available


  454. OH CE, Kwon GY, Kwon YH, Lee EJ, et al
    High tuberculosis transmission rate in children with nursery exposure to undetected pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:1031-1036.
    PubMed     Abstract available


  455. SWINDELLS S, Gupta A, Kim S, Hughes MD, et al
    Resource utilization for multidrug-resistant tuberculosis household contact investigations (A5300/I2003).
    Int J Tuberc Lung Dis. 2018;22:1016-1022.
    PubMed     Abstract available


  456. MONK EJM, Kumwenda M, Nliwasa M, Mpunga J, et al
    Factors affecting tuberculosis health message recall 2 years after active case finding in Blantyre, Malawi.
    Int J Tuberc Lung Dis. 2018;22:1007-1015.
    PubMed     Abstract available


  457. ZUUR MA, van Asselt ADI, van 't Boveneind-Vrubleuskaya N, Aleksa A, et al
    Cost-utility analysis of high-dose treatment for intermediate-susceptible, dose-dependent tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:991-999.
    PubMed     Abstract available


  458. NHUNG NV, Hoa NB, Anh NT, Anh LTN, et al
    Measuring catastrophic costs due to tuberculosis in Viet Nam.
    Int J Tuberc Lung Dis. 2018;22:983-990.
    PubMed     Abstract available


  459. DONALD PR, Diacon AH, Lange C, Demers AM, et al
    Droplets, dust and guinea pigs: an historical review of tuberculosis transmission research, 1878-1940.
    Int J Tuberc Lung Dis. 2018;22:972-982.
    PubMed     Abstract available


  460. SCHWARTZMAN K
    You pay for what you get: the true cost of tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:969.
    PubMed    


    August 2018
  461. CHAN ED
    Thin body habitus is a risk factor for active pulmonary tuberculosis, but not for infection.
    Int J Tuberc Lung Dis. 2018;22:967-968.
    PubMed    


  462. ZELLWEGER JP
    Multidrug-resistant tuberculosis in Ukraine: what is hidden behind the numbers?
    Int J Tuberc Lung Dis. 2018;22:966-967.
    PubMed    


  463. YAN ZH, Yi L, Wei PJ, Jia HY, et al
    Evaluation of panels of Mycobacterium tuberculosis antigens for serodiagnosis of tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:959-965.
    PubMed     Abstract available


  464. DUPNIK KM, Bean JM, Lee MH, Jean Juste MA, et al
    Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum.
    Int J Tuberc Lung Dis. 2018;22:950-958.
    PubMed     Abstract available


  465. RAJOLI RKR, Podany AT, Moss DM, Swindells S, et al
    Modelling the long-acting administration of anti-tuberculosis agents using PBPK: a proof of concept study.
    Int J Tuberc Lung Dis. 2018;22:937-944.
    PubMed     Abstract available


  466. ZHU H, Guo SC, Liu ZQ, Wang B, et al
    Therapeutic drug monitoring of cycloserine and linezolid during anti-tuberculosis treatment in Beijing, China.
    Int J Tuberc Lung Dis. 2018;22:931-936.
    PubMed     Abstract available


  467. COURT RG, Wiesner L, Chirehwa MT, Stewart A, et al
    Effect of lidocaine on kanamycin injection-site pain in patients with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:926-930.
    PubMed     Abstract available


  468. SCHNIPPEL K, Firnhaber C, Page-Shipp L, Sinanovic E, et al
    Impact of adverse drug reactions on the incremental cost-effectiveness of bedaquiline for drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:918-925.
    PubMed     Abstract available


  469. NAM VX, Nhung NV, Hoa NB, Thuy HTT, et al
    Economic burden of multidrug-resistant tuberculosis: a multicenter study across Vietnamese regions.
    Int J Tuberc Lung Dis. 2018;22:912-917.
    PubMed     Abstract available


  470. COLLINS D, Beyene D, Tedla Y, Mesfin H, et al
    Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia?
    Int J Tuberc Lung Dis. 2018;22:905-911.
    PubMed     Abstract available


  471. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    Improving rifampicin-resistant tuberculosis diagnosis using Xpert((R)) MTB/RIF: modelling interventions and costs.
    Int J Tuberc Lung Dis. 2018;22:890-898.
    PubMed     Abstract available


  472. CHAUDHARY A, Singh JP, Sehajpal PK, Sarin BC, et al
    P2X7 receptor polymorphisms and susceptibility to tuberculosis in a North Indian Punjabi population.
    Int J Tuberc Lung Dis. 2018;22:884-889.
    PubMed     Abstract available


  473. CHAWLA K, Kumar A, Shenoy VP, Chauhan DS, et al
    Strain diversity and relative transmission of Mycobacterium tuberculosis in south coastal Karnataka, India.
    Int J Tuberc Lung Dis. 2018;22:878-883.
    PubMed     Abstract available


  474. VAN DER HEIJDEN YF, Karim F, Chinappa T, Mufamadi G, et al
    Older age at first tuberculosis diagnosis is associated with tuberculosis recurrence in HIV-negative persons.
    Int J Tuberc Lung Dis. 2018;22:871-877.
    PubMed     Abstract available


  475. TURNER RD, Birring SS, Darmalingam M, Hooper RL, et al
    Daily cough frequency in tuberculosis and association with household infection.
    Int J Tuberc Lung Dis. 2018;22:863-870.
    PubMed     Abstract available


  476. HIRSCH-MOVERMAN Y, Mantell JE, Lebelo L, Wynn C, et al
    Tuberculosis preventive treatment preferences among care givers of children in Lesotho: a pilot study.
    Int J Tuberc Lung Dis. 2018;22:858-862.
    PubMed     Abstract available


  477. MALIK AA, Amanullah F, Codlin AJ, Siddiqui S, et al
    Improving childhood tuberculosis detection and treatment through facility-based screening in rural Pakistan.
    Int J Tuberc Lung Dis. 2018;22:851-857.
    PubMed     Abstract available


  478. SHETE PB, Boccia D, Dhavan P, Gebreselassie N, et al
    Defining a migrant-inclusive tuberculosis research agenda to end TB.
    Int J Tuberc Lung Dis. 2018;22:835-843.
    PubMed     Abstract available


  479. DOOLEY KE
    Long-acting injectables for tuberculosis prophylaxis and treatment: is now the time?
    Int J Tuberc Lung Dis. 2018;22:833-834.
    PubMed    


  480. CAMINERO JA, Scardigli A
    The economic burden of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:831-832.
    PubMed    


  481. SOMOSKOVI A, Gutierrez C
    Gaps in understanding factors influencing tuberculosis recurrence.
    Int J Tuberc Lung Dis. 2018;22:830.
    PubMed    


    July 2018
  482. HYDER MKA, Tripathy JP, Kaur J, Mandal PP, et al
    Tuberculosis-tobacco integration in the South-East Asia Region: policy analysis and implementation framework.
    Int J Tuberc Lung Dis. 2018;22:807-812.
    PubMed     Abstract available


  483. SINHA P, Moll AP, Brooks RP, Deng YH, et al
    Synergism between diabetes and human immunodeficiency virus in increasing the risk of tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:793-799.
    PubMed     Abstract available


  484. SCHININA V, Albarello F, Cristofaro M, Di Stefano F, et al
    Diagnostic imaging of hepatic tuberculosis: case series.
    Int J Tuberc Lung Dis. 2018;22:779-787.
    PubMed     Abstract available


  485. WALKER IF, Khan AM, Khan AM, Khan NM, et al
    Depression among multidrug-resistant tuberculosis patients in Punjab, Pakistan: a large cross-sectional study.
    Int J Tuberc Lung Dis. 2018;22:773-778.
    PubMed     Abstract available


  486. ODAYAR J, Rangaka MX, Zerbe A, Petro G, et al
    Burden of tuberculosis in HIV-positive pregnant women in Cape Town, South Africa.
    Int J Tuberc Lung Dis. 2018;22:760-765.
    PubMed     Abstract available


  487. GIMENEZ-DURAN J, Galmes-Truyols A, Gonzalez-Cortijo T, Portell-Arbona M, et al
    Capture-recapture and anti-tuberculosis drug prescriptions, Balearic Islands, Spain, 2010-2012.
    Int J Tuberc Lung Dis. 2018;22:754-759.
    PubMed     Abstract available


  488. REEVE BWP, McFall SM, Song R, Warren R, et al
    Commercial products to preserve specimens for tuberculosis diagnosis: a systematic review.
    Int J Tuberc Lung Dis. 2018;22:741-753.
    PubMed     Abstract available


  489. MULLER AM, Osorio CS, Silva DR, Sbruzzi G, et al
    Interventions to improve adherence to tuberculosis treatment: systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2018;22:731-740.
    PubMed     Abstract available


  490. FLOYD K, Glaziou P, Houben RMGJ, Sumner T, et al
    Global tuberculosis targets and milestones set for 2016-2035: definition and rationale.
    Int J Tuberc Lung Dis. 2018;22:723-730.
    PubMed     Abstract available


  491. WINTER JR, Adamu AL, Gupta RK, Stagg HR, et al
    Tuberculosis infection and disease in people living with HIV in countries with low tuberculosis incidence.
    Int J Tuberc Lung Dis. 2018;22:713-722.
    PubMed     Abstract available


  492. CASTRO KG, Colvin CE
    Updated global tuberculosis targets: a welcome ambition in need of attention to quality of care.
    Int J Tuberc Lung Dis. 2018;22:709.
    PubMed    


  493. GUPTE AN, Mave V, Meshram S, Lokhande R, et al
    Trends in HbA1c levels and implications for diabetes screening in tuberculosis cases undergoing treatment in India.
    Int J Tuberc Lung Dis. 2018;22:800-806.
    PubMed     Abstract available


  494. JEYASHREE K, Nayak P
    TB and tobacco integration: what is missing and what can we expect?
    Int J Tuberc Lung Dis. 2018;22:711.
    PubMed    


  495. BARRY PM, True L
    Using evidence to improve adherence and outcomes: personalized packages of patient support.
    Int J Tuberc Lung Dis. 2018;22:710.
    PubMed    


    June 2018
  496. YABLONSKII PK, Avetisyan AO, Vasilev IV, Kudriashov GG, et al
    Robot-assisted lobectomy for pulmonary tuberculosis in a case with immunosuppression after kidney transplantation.
    Int J Tuberc Lung Dis. 2018;22:704-705.
    PubMed    


  497. SHIVAKUMAR SVBY, Chandrasekaran P, Kumar AMV, Paradkar M, et al
    Diabetes and pre-diabetes among household contacts of tuberculosis patients in India: is it time to screen them all?
    Int J Tuberc Lung Dis. 2018;22:686-694.
    PubMed     Abstract available


  498. CHIEN K, Seemangal J, Batt J, Vozoris NT, et al
    Abdominal tuberculosis: a descriptive case series of the experience in a Canadian tuberculosis clinic.
    Int J Tuberc Lung Dis. 2018;22:681-685.
    PubMed     Abstract available


  499. JACOBS MG, Pelissari DM, Pinto VL
    Factors associated with the drug-resistant tuberculosis incidence rate in Brazil.
    Int J Tuberc Lung Dis. 2018;22:675-680.
    PubMed     Abstract available


  500. LIU Y, Zheng Y, Chen J, Shi Y, et al
    Tuberculosis-associated mortality and its risk factors in a district of Shanghai, China: a retrospective cohort study.
    Int J Tuberc Lung Dis. 2018;22:655-660.
    PubMed     Abstract available


  501. MANSOUR O, Masini EO, Kim BJ, Kamene M, et al
    Impact of a national nutritional support programme on loss to follow-up after tuberculosis diagnosis in Kenya.
    Int J Tuberc Lung Dis. 2018;22:649-654.
    PubMed     Abstract available


  502. BOURGEOIS AC, Zulz T, Bruce MG, Stenz F, et al
    Tuberculosis in the Circumpolar Region, 2006-2012.
    Int J Tuberc Lung Dis. 2018;22:641-648.
    PubMed     Abstract available


  503. WANG KY, Lin YS, Sy CL, Huang WC, et al
    Hyperbaric oxygen therapy increases the risk of tuberculosis disease.
    Int J Tuberc Lung Dis. 2018;22:637-640.
    PubMed     Abstract available


  504. YANG ZH, Gorden T, Liu DP, Mukasa L, et al
    Increasing likelihood of advanced pulmonary tuberculosis at initial diagnosis in a low-incidence US state.
    Int J Tuberc Lung Dis. 2018;22:628-636.
    PubMed     Abstract available


  505. POPE V, Sacksteder KA, Hererra JC, Gilman RH, et al
    MPT64 patch test for the diagnosis of active pulmonary tuberculosis: a randomised controlled trial in Peru.
    Int J Tuberc Lung Dis. 2018;22:622-627.
    PubMed     Abstract available


  506. HORNE DJ, Jones BE, Kamada A, Fukushima K, et al
    Multicenter study of QuantiFERON((R))-TB Gold Plus in patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:617-621.
    PubMed     Abstract available


  507. WHITE RG, Charalambous S, Cardenas V, Hippner P, et al
    Evidence-informed policy making at country level: lessons learned from the South African Tuberculosis Think Tank.
    Int J Tuberc Lung Dis. 2018;22:606-613.
    PubMed     Abstract available


  508. DARA M, Zachariah R
    Hunger and tuberculosis: two sides of the same coin.
    Int J Tuberc Lung Dis. 2018;22:592.
    PubMed    


  509. MAGEE MJ, Gandhi NR, Kornfeld H
    A dual purpose for household contact investigations: preventing TB disease and improving diabetes outcomes.
    Int J Tuberc Lung Dis. 2018;22:594-595.
    PubMed    


  510. SOTGIU G, Loddenkemper R
    Insufficient pharmacological research on TB drugs: new insights on safety are needed.
    Int J Tuberc Lung Dis. 2018;22:593.
    PubMed    


  511. VAN LETH F, Sester M
    Testing for LTBI: more of the same or a step forward?
    Int J Tuberc Lung Dis. 2018;22:591.
    PubMed    


    May 2018
  512. KIM S, Seddon JA, Garcia-Prats AJ, Montepiedra G, et al
    Statistical considerations for pediatric multidrug-resistant tuberculosis efficacy trials.
    Int J Tuberc Lung Dis. 2018;22:34-39.
    PubMed     Abstract available


  513. GARCIA-PRATS AJ, Svensson EM, Weld ED, Schaaf HS, et al
    Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in children.
    Int J Tuberc Lung Dis. 2018;22:15-23.
    PubMed     Abstract available


  514. TUCKER EW, Dooley KE
    Preclinical tools for the evaluation of tuberculosis treatment regimens for children.
    Int J Tuberc Lung Dis. 2018;22:7-14.
    PubMed     Abstract available


  515. JENKINS HE, Yuen CM
    The burden of multidrug-resistant tuberculosis in children.
    Int J Tuberc Lung Dis. 2018;22:3-6.
    PubMed     Abstract available


  516. LALOR MK, Mohiyuddin T, Uddin T, Thomas HL, et al
    The challenge of estimating tuberculosis mortality accurately in England and Wales.
    Int J Tuberc Lung Dis. 2018;22:572-578.
    PubMed     Abstract available


  517. MELENDEZ J, Hogeweg L, Sanchez CI, Philipsen RHHM, et al
    Accuracy of an automated system for tuberculosis detection on chest radiographs in high-risk screening.
    Int J Tuberc Lung Dis. 2018;22:567-571.
    PubMed     Abstract available


  518. KUHLIN J, Smith C, Khaemraev A, Tigay Z, et al
    Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan.
    Int J Tuberc Lung Dis. 2018;22:544-550.
    PubMed     Abstract available


  519. GGITA JM, Ojok C, Meyer AJ, Farr K, et al
    Patterns of usage and preferences of users for tuberculosis-related text messages and voice calls in Uganda.
    Int J Tuberc Lung Dis. 2018;22:530-536.
    PubMed     Abstract available


  520. MERID Y, Woldeamanuel Y, Abebe M, Datiko DG, et al
    High utility of active tuberculosis case finding in an Ethiopian prison.
    Int J Tuberc Lung Dis. 2018;22:524-529.
    PubMed     Abstract available


  521. KAWATSU L, Uchimura K, Izumi K, Ohkado A, et al
    Using surveillance data to simulate the impact of a hypothetical pre-entry tuberculosis screening programme in Japan.
    Int J Tuberc Lung Dis. 2018;22:510-517.
    PubMed     Abstract available


  522. SOHN H, Kim HY, Lee SH
    Cost-effectiveness of contact screening strategies for tuberculosis among high-school adolescents in South Korea.
    Int J Tuberc Lung Dis. 2018;22:496-503.
    PubMed     Abstract available


  523. BYAMUNGU LN, du Preez K, Walters E, Nachega JB, et al
    Timing of HIV diagnosis in children with tuberculosis managed at a referral hospital in Cape Town, South Africa.
    Int J Tuberc Lung Dis. 2018;22:488-495.
    PubMed     Abstract available


  524. GUPTA RK, Lipman M, Story A, Hayward A, et al
    Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era.
    Int J Tuberc Lung Dis. 2018;22:479-487.
    PubMed     Abstract available


  525. VELASQUEZ GE, Davies GR, Mitnick CD
    Making up the difference: ensuring the bioequivalence of fixed-dose combinations for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:473-474.
    PubMed    


  526. TWEED C, Nunn A
    Data in TB have to be both big and good.
    Int J Tuberc Lung Dis. 2018;22:476.
    PubMed    


  527. JOHNSON DF, Stout JE
    Corticosteroids for tuberculous pericarditis: can we learn from variability?
    Int J Tuberc Lung Dis. 2018;22:475.
    PubMed    


    April 2018
  528. HARRIES AD
    Impact of antiretroviral therapy on tuberculosis control.
    Int J Tuberc Lung Dis. 2018;22:466-467.
    PubMed    


  529. PAYEN MC, De Wit S
    In Reply: Synergy between amoxicillin and meropenem/clavulanate in drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:465-466.
    PubMed    


  530. MISHRA GP, Caminero JA
    Low-dose amoxicillin-clavulanate in drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:465.
    PubMed    


  531. CLICK ES, Ouma GS, DeGruy K, Murithi W, et al
    No evidence of Mycobacterium tuberculosis in breast milk of 18 women with confirmed TB disease in Kisumu, Kenya.
    Int J Tuberc Lung Dis. 2018;22:464-465.
    PubMed    


  532. MATHYS V, Roycroft E, Raftery P, Groenheit R, et al
    Time-and-motion tool for the assessment of working time in tuberculosis laboratories: a multicentre study.
    Int J Tuberc Lung Dis. 2018;22:444-451.
    PubMed     Abstract available


  533. BASHAM CA, Elias B, Fanning A, Cook C, et al
    Performance measurement of a Canadian provincial tuberculosis programme: Manitoba, 2008-2012.
    Int J Tuberc Lung Dis. 2018;22:437-443.
    PubMed     Abstract available


  534. MASKERY B, Posey DL, Coleman MS, Asis R, et al
    Economic analysis of CDC's culture- and smear-based tuberculosis instructions for Filipino immigrants.
    Int J Tuberc Lung Dis. 2018;22:429-436.
    PubMed     Abstract available


  535. ADEPOYIBI T, Lilis L, Greb H, Boyle D, et al
    Which attributes within target product profiles for tuberculosis diagnostics are the most important to focus on?
    Int J Tuberc Lung Dis. 2018;22:425-428.
    PubMed     Abstract available


  536. YADAV R, Saini A, Kaur P, Behera D, et al
    Diagnostic accuracy of GenoType((R)) MTBDRsl VER 2.0 in detecting second-line drug resistance to M. tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:419-424.
    PubMed     Abstract available


  537. COX V, Brigden G, Crespo RH, Lessem E, et al
    Global programmatic use of bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:407-412.
    PubMed     Abstract available


  538. HEYCKENDORF J, van Leth F, Avsar K, Glattki G, et al
    Treatment responses in multidrug-resistant tuberculosis in Germany.
    Int J Tuberc Lung Dis. 2018;22:399-406.
    PubMed     Abstract available


  539. SCHNIPPEL K, Firnhaber C, Berhanu R, Page-Shipp L, et al
    Direct costs of managing adverse drug reactions during rifampicin-resistant tuberculosis treatment in South Africa.
    Int J Tuberc Lung Dis. 2018;22:393-398.
    PubMed     Abstract available


  540. HTET KKK, Soe KT, Kumar AMV, Saw S, et al
    Rifampicin-resistant tuberculosis patients in Myanmar in 2016: how many are lost on the path to treatment?
    Int J Tuberc Lung Dis. 2018;22:385-392.
    PubMed     Abstract available


  541. ONYOH EF, Kuaban C, Lin HH
    Pre-treatment loss to follow-up of pulmonary tuberculosis patients in two regions of Cameroon.
    Int J Tuberc Lung Dis. 2018;22:378-384.
    PubMed     Abstract available


  542. SHIN SS, Modongo C, Zetola NM, Wang Q, et al
    High rates of exposure to tuberculosis patients among HIV-infected health care workers in Botswana.
    Int J Tuberc Lung Dis. 2018;22:366-370.
    PubMed     Abstract available


  543. REAVES EJ, Shah S, France AM, Morris SB, et al
    In Reply: Latent tuberculous infection testing among HIV-infected persons in clinical care.
    Int J Tuberc Lung Dis. 2018;22:468-469.
    PubMed    


  544. VAN BENTUM P, Swanink CMA, van Lochem EG, Claassen MAA, et al
    Prevalence of latent tuberculous infection among HIV-infected patients in a Dutch out-patient clinic.
    Int J Tuberc Lung Dis. 2018;22:467-468.
    PubMed    


  545. UPLEKAR M
    Using new TB tools: global rhetoric and ground reality.
    Int J Tuberc Lung Dis. 2018;22:357.
    PubMed    


  546. BAKER BJ
    ART and lifelong IPT for health care workers with HIV: a priority for infection control.
    Int J Tuberc Lung Dis. 2018;22:356.
    PubMed    


  547. TAN WC
    Low body mass index and latent tuberculous infection: current evidence?
    Int J Tuberc Lung Dis. 2018;22:355.
    PubMed    


    March 2018
  548. JACOBS C, Goussard P, Gie RP
    Mycobacterium tuberculosis, a cause of necrotising pneumonia in childhood: a case series.
    Int J Tuberc Lung Dis. 2018 Mar 22. doi: 10.5588/ijtld.17.0570.
    PubMed     Abstract available


  549. NAMIIRO S, Wobudeya E, Colebunders R, Worodria W, et al
    Molecular tests expedite the diagnosis of multidrug-resistant tuberculosis in childhood.
    Int J Tuberc Lung Dis. 2018;22:349-350.
    PubMed    


  550. BRUMWELL A, Noyes E, Kulkarni S, Lin V, et al
    A rapid review of treatment literacy materials for tuberculosis patients.
    Int J Tuberc Lung Dis. 2018;22:336-341.
    PubMed     Abstract available


  551. BECKER AS, Bluthgen C, Phi van VD, Sekaggya-Wiltshire C, et al
    Detection of tuberculosis patterns in digital photographs of chest X-ray images using Deep Learning: feasibility study.
    Int J Tuberc Lung Dis. 2018;22:328-335.
    PubMed     Abstract available


  552. D'ATTILIO L, Diaz A, Fernandez RDV, Bongiovanni B, et al
    The neuro-endocrine-immune relationship in pulmonary and pleural tuberculosis: a better local profile in pleural fluid.
    Int J Tuberc Lung Dis. 2018;22:321-327.
    PubMed     Abstract available


  553. OLARU ID, Albert H, Zallet J, Werner UE, et al
    Impact of quality improvement in tuberculosis laboratories in low- and lower-middle-income countries: a systematic review.
    Int J Tuberc Lung Dis. 2018;22:309-320.
    PubMed     Abstract available


  554. BARK CM, Thiel BA, Ogwang S, Sekitoleko I, et al
    Sputum smear-positive, culture-negative state during anti-tuberculosis treatment in the MGIT liquid culture era.
    Int J Tuberc Lung Dis. 2018;22:306-308.
    PubMed     Abstract available


  555. FAN YM, Ding SP, Bao ZJ, Wu LM, et al
    Prognostic factors for treatment success in patients with multidrug-resistant tuberculosis in China.
    Int J Tuberc Lung Dis. 2018;22:300-305.
    PubMed     Abstract available


  556. FRANCIS JR, Manchikanti P, Blyth CC, Denholm J, et al
    Multidrug-resistant tuberculosis in Australia, 1998-2012.
    Int J Tuberc Lung Dis. 2018;22:294-299.
    PubMed     Abstract available


  557. SMITH CM, Lessells R, Grant AD, Herbst K, et al
    Spatial clustering of drug-resistant tuberculosis in Hlabisa subdistrict, KwaZulu-Natal, 2011-2015.
    Int J Tuberc Lung Dis. 2018;22:287-293.
    PubMed     Abstract available


  558. NGWIRA LG, Dowdy DW, Khundi M, Barnes GL, et al
    Delay in seeking care for tuberculosis symptoms among adults newly diagnosed with HIV in rural Malawi.
    Int J Tuberc Lung Dis. 2018;22:280-286.
    PubMed     Abstract available


  559. KWEZA PF, Van Schalkwyk C, Abraham N, Uys M, et al
    Estimating the magnitude of pulmonary tuberculosis patients missed by primary health care clinics in South Africa.
    Int J Tuberc Lung Dis. 2018;22:264-272.
    PubMed     Abstract available


  560. FURTADO DA LUZ E, Braga JU
    Under-reporting of tuberculosis in Praia, Cape Verde, from 2006 to 2012.
    Int J Tuberc Lung Dis. 2018;22:258-263.
    PubMed     Abstract available


  561. DAVIDSON JA, Fulton N, Thomas HL, Lalor MK, et al
    Investigating a tuberculosis cluster among Filipino health care workers in a low-incidence country.
    Int J Tuberc Lung Dis. 2018;22:252-257.
    PubMed     Abstract available


  562. VAN DEUN A, Decroo T, Piubello A, de Jong BC, et al
    Principles for constructing a tuberculosis treatment regimen: the role and definition of core and companion drugs.
    Int J Tuberc Lung Dis. 2018;22:239-245.
    PubMed     Abstract available


  563. ENGEL N
    Towards patient-centred care: analysing TB treatment literacy documents and adherence discourses.
    Int J Tuberc Lung Dis. 2018;22:238.
    PubMed    


  564. RIDZON R
    The tip of the iceberg.
    Int J Tuberc Lung Dis. 2018;22:237.
    PubMed    


    February 2018
  565. ALSHEVSKAYA AA, Kireev FD, Laushkina ZA, Lopatnikova JA, et al
    Enhanced expression of TNF-alpha type-1 receptors by immune cells in active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:212-220.
    PubMed     Abstract available


  566. BAIRD T, Donnan E, Coulter C, Simpson G, et al
    Multidrug-resistant tuberculosis in Queensland, Australia: an ongoing cross-border challenge.
    Int J Tuberc Lung Dis. 2018;22:206-211.
    PubMed     Abstract available


  567. PAVLENKO E, Barbova A, Hovhannesyan A, Tsenilova Z, et al
    Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey.
    Int J Tuberc Lung Dis. 2018;22:197-205.
    PubMed     Abstract available


  568. ANTHONY-WILLIAMS MH, Farrugia BB, Montefort S
    Tuberculosis notification and treatment outcome among migrant boat arrivals in Malta, 2007-2011.
    Int J Tuberc Lung Dis. 2018;22:194-196.
    PubMed     Abstract available


  569. TAHSEEN S, Shahnawaz H, Riaz U, Khanzada FM, et al
    Systematic case finding for tuberculosis in HIV-infected people who inject drugs: experience from Pakistan.
    Int J Tuberc Lung Dis. 2018;22:187-193.
    PubMed     Abstract available


  570. JIAMSAKUL A, Lee MP, Nguyen KV, Merati TP, et al
    Socio-economic status and risk of tuberculosis: a case-control study of HIV-infected patients in Asia.
    Int J Tuberc Lung Dis. 2018;22:179-186.
    PubMed     Abstract available


  571. DE CASTRO DB, Sadahiro M, Pinto RC, de Albuquerque BC, et al
    Spatial distribution of tuberculosis in Manaus and its social determinants, 2008-2013.
    Int J Tuberc Lung Dis. 2018;22:171-178.
    PubMed     Abstract available


  572. ROSSER A, Marx FM, Pareek M
    Recurrent tuberculosis in the pre-elimination era.
    Int J Tuberc Lung Dis. 2018;22:139-150.
    PubMed     Abstract available


  573. ODONE A, Roberts B, Dara M, van den Boom M, et al
    People- and patient-centred care for tuberculosis: models of care for tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:133-138.
    PubMed     Abstract available


  574. DUDNYK A, Chesov D, Lange C
    Mission impossible: the End TB strategy.
    Int J Tuberc Lung Dis. 2018;22:121-122.
    PubMed    


  575. MULLINS J, Lobato MN, Bemis K, Sosa L, et al
    Spatial clusters of latent tuberculous infection, Connecticut, 2010-2014.
    Int J Tuberc Lung Dis. 2018;22:165-170.
    PubMed     Abstract available


  576. SULIS G, Carvalho ACC, Capone S, Hamada Y, et al
    Policies and practices on the programmatic management of LTBI: a survey in the African Region.
    Int J Tuberc Lung Dis. 2018;22:158-164.
    PubMed     Abstract available


  577. SWINDELLS S, Siccardi M, Barrett SE, Olsen DB, et al
    Long-acting formulations for the treatment of latent tuberculous infection: opportunities and challenges.
    Int J Tuberc Lung Dis. 2018;22:125-132.
    PubMed     Abstract available


    January 2018
  578. BYRNE AL, Marais BJ, Mitnick CD, Garden FL, et al
    Feasibility and yield of screening for non-communicable diseases among treated tuberculosis patients in Peru.
    Int J Tuberc Lung Dis. 2018;22:86-92.
    PubMed     Abstract available


  579. PINTO PFPS, Neto FC, de Almeida Ribeiro MCS
    Tuberculosis among South American immigrants in Sao Paulo municipality: an analysis in space and time.
    Int J Tuberc Lung Dis. 2018;22:80-85.
    PubMed     Abstract available


  580. WONG J, Lowenthal P, Flood J, Watt J, et al
    Increased tuberculosis risk among immigrants arriving in California with abnormal domestic chest radiographs.
    Int J Tuberc Lung Dis. 2018;22:73-79.
    PubMed     Abstract available


  581. SHIMAZAKI T, Taniguchi T, Saludar NRD, Gustilo LM, et al
    Bacterial co-infection and early mortality among pulmonary tuberculosis patients in Manila, The Philippines.
    Int J Tuberc Lung Dis. 2018;22:65-72.
    PubMed     Abstract available


  582. LEE B, Oh HJ, Chon BS
    Estimating the impact of a television campaign on tuberculosis knowledge and intention to test for TB in South Korea.
    Int J Tuberc Lung Dis. 2018;22:60-64.
    PubMed     Abstract available


  583. GUGLIELMETTI L, Veziris N, Aubry A, Brossier F, et al
    Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Int J Tuberc Lung Dis. 2018;22:54-59.
    PubMed     Abstract available


  584. EI PW, Aung WW, Nyunt WW, Swe TL, et al
    Extensively drug-resistant tuberculosis in Myanmar: burden and mutations causing second-line drug resistance.
    Int J Tuberc Lung Dis. 2018;22:47-53.
    PubMed     Abstract available


  585. LOVEDAY M, Sunkari B, Master I, Daftary A, et al
    Household context and psychosocial impact of childhood multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa.
    Int J Tuberc Lung Dis. 2018;22:40-46.
    PubMed     Abstract available


  586. PAYEN MC, Muylle I, Vandenberg O, Mathys V, et al
    Meropenem-clavulanate for drug-resistant tuberculosis: a follow-up of relapse-free cases.
    Int J Tuberc Lung Dis. 2018;22:34-39.
    PubMed     Abstract available


  587. COURT R, Wiesner L, Stewart A, de Vries N, et al
    Steady state pharmacokinetics of cycloserine in patients on terizidone for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2018;22:30-33.
    PubMed     Abstract available


  588. LEE PH, Fu H, Lee MR, Magee M, et al
    Tuberculosis and diabetes in low and moderate tuberculosis incidence countries.
    Int J Tuberc Lung Dis. 2018;22:7-16.
    PubMed     Abstract available


  589. JACKSON C, Cohen T, Rangaka MX, Abubakar I, et al
    Eliminating tuberculosis in low-burden countries.
    Int J Tuberc Lung Dis. 2018;22:3.
    PubMed    


  590. ALFFENAAR JWC, Peloquin CA, Migliori GB
    Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
    Int J Tuberc Lung Dis. 2018;22:2.
    PubMed    


    December 2017
  591. NANSUMBA M, Kumbakumba E, Orikiriza P, Bastard M, et al
    Treatment outcomes and tolerability of the revised WHO anti-tuberculosis drug dosages for children.
    Int J Tuberc Lung Dis. 2017 Dec 20. doi: 10.5588/ijtld.17.0535.
    PubMed     Abstract available


  592. ALLWOOD BW, van Zyl-Smit R
    Tuberculosis, chronic obstructive pulmonary disease and inhaled corticosteroids: a complex web.
    Int J Tuberc Lung Dis. 2017;21:1317-1318.
    PubMed    


  593. ZELLWEGER JP
    Depression and risk of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1314.
    PubMed    


  594. YU ZG, Wang BZ, Li J, Ding ZL, et al
    Association between interleukin-17 genetic polymorphisms and tuberculosis susceptibility: an updated meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1307-1313.
    PubMed     Abstract available


  595. SHU E, Sobieszczyk ME, Sal Y Rosas VG, Segura P, et al
    Knowledge of tuberculosis and vaccine trial preparedness in Lima, Peru.
    Int J Tuberc Lung Dis. 2017;21:1288-1293.
    PubMed     Abstract available


  596. MAVE V, Meshram S, Lokhande R, Kadam D, et al
    Prevalence of dysglycemia and clinical presentation of pulmonary tuberculosis in Western India.
    Int J Tuberc Lung Dis. 2017;21:1280-1287.
    PubMed     Abstract available


  597. DELORY T, Ferrand H, Grall N, Casalino E, et al
    Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area.
    Int J Tuberc Lung Dis. 2017;21:1272-1279.
    PubMed     Abstract available


  598. DALE K, Tay E, Trauer JM, Trevan P, et al
    Gender differences in tuberculosis diagnosis, treatment and outcomes in Victoria, Australia, 2002-2015.
    Int J Tuberc Lung Dis. 2017;21:1264-1271.
    PubMed     Abstract available


  599. KUMWENDA M, Nyang'wa BT, Chikuse B, Biseck T, et al
    The second sputum sample complicates tuberculosis diagnosis for women: a qualitative study from Malawi.
    Int J Tuberc Lung Dis. 2017;21:1258-1263.
    PubMed     Abstract available


  600. NAGU T, Ray R, Munseri P, Moshiro C, et al
    Tuberculosis among the elderly in Tanzania: disease presentation and initial response to treatment.
    Int J Tuberc Lung Dis. 2017;21:1251-1257.
    PubMed     Abstract available


  601. MOH R, Badje A, N'takpe JB, Kouame GM, et al
    Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adults.
    Int J Tuberc Lung Dis. 2017;21:1237-1244.
    PubMed     Abstract available


  602. SURETTE MA, Beattie P, Nyirenda T, Olesen OF, et al
    Tackling tuberculosis in sub-Saharan Africa: EDCTP achievements and the road ahead.
    Int J Tuberc Lung Dis. 2017;21:1220-1229.
    PubMed     Abstract available


  603. HUANGFU P, Pearson F, Ugarte-Gil C, Critchley J, et al
    Diabetes and poor tuberculosis treatment outcomes: issues and implications in data interpretation and analysis.
    Int J Tuberc Lung Dis. 2017;21:1214-1219.
    PubMed     Abstract available


  604. COX V, Furin J
    World Health Organization recommendations for multidrug-resistant tuberculosis: should different standards be applied?
    Int J Tuberc Lung Dis. 2017;21:1211-1213.
    PubMed     Abstract available


    November 2017
  605. TREBUCQ A, Schwoebel V, Kashongwe Z, Bakayoko A, et al
    Treatment outcome with a short multidrug-resistant tuberculosis regimen in nine African countries.
    Int J Tuberc Lung Dis. 2017 Nov 17. doi: 10.5588/ijtld.17.0498.
    PubMed     Abstract available


  606. MAARTENS G, Brill MJE, Pandie M, Svensson EM, et al
    Pharmacokinetic interaction between bedaquiline and clofazimine in patients with drug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017 Nov 16. doi: 10.5588/ijtld.17.0615.
    PubMed     Abstract available


  607. BOYD R, Ford N, Padgen P, Cox H, et al
    Time to treatment for rifampicin-resistant tuberculosis: systematic review and meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1173-1180.
    PubMed     Abstract available


  608. MUCHENA G, Shambira G, Masuka N, Juru T, et al
    Determinants of multidrug resistance among previously treated tuberculosis patients in Zimbabwe, 2014.
    Int J Tuberc Lung Dis. 2017;21:1167-1172.
    PubMed     Abstract available


  609. GARCIA-GOEZ JF, Munera GA, Rojas V, Pacheco R, et al
    Tuberculosis in recipients of solid-organ transplants during 1995-2015 in Cali, Colombia.
    Int J Tuberc Lung Dis. 2017;21:1155-1159.
    PubMed     Abstract available


  610. KHAN PY, Crampin AC, Mzembe T, Koole O, et al
    Does antiretroviral treatment increase the infectiousness of smear-positive pulmonary tuberculosis?
    Int J Tuberc Lung Dis. 2017;21:1147-1154.
    PubMed     Abstract available


  611. RIVERA VR, Jean-Juste MA, Gluck SC, Reeder HT, et al
    Diagnostic yield of active case finding for tuberculosis and HIV at the household level in slums in Haiti.
    Int J Tuberc Lung Dis. 2017;21:1140-1146.
    PubMed     Abstract available


  612. CHEN C, Yang CG, Gao X, Lu ZZ, et al
    Community-based active case finding for tuberculosis in rural western China: a cross-sectional study.
    Int J Tuberc Lung Dis. 2017;21:1134-1139.
    PubMed     Abstract available


  613. MULDER C, Mgode GF, Ellis H, Valverde E, et al
    Accuracy of giant African pouched rats for diagnosing tuberculosis: comparison with culture and Xpert(R) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:1127-1133.
    PubMed     Abstract available


  614. WELLS WA
    Onions and prevalence surveys: how to analyze and quantify tuberculosis case-finding gaps.
    Int J Tuberc Lung Dis. 2017;21:1101-1113.
    PubMed     Abstract available


  615. BAO J, Hafner R
    Conducting high-quality tuberculosis clinical trials in China: opportunities and challenges.
    Int J Tuberc Lung Dis. 2017;21:1094-1100.
    PubMed     Abstract available


  616. BORGDORFF MW, De Cock KM
    Provision of ART to individuals infected with HIV: impact on the epidemiology and control of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1091-1092.
    PubMed    


  617. MACINTYRE K, Bakker MI, Bergson S, Bhavaraju R, et al
    Defining the research agenda to measure and reduce tuberculosis stigmas.
    Int J Tuberc Lung Dis. 2017;21:87-96.
    PubMed     Abstract available


  618. SOMMERLAND N, Wouters E, Mitchell EMH, Ngicho M, et al
    Evidence-based interventions to reduce tuberculosis stigma: a systematic review.
    Int J Tuberc Lung Dis. 2017;21:81-86.
    PubMed     Abstract available


  619. SOMMERLAND N, Wouters E, Masquillier C, Engelbrecht M, et al
    Stigma as a barrier to the use of occupational health units for tuberculosis services in South Africa.
    Int J Tuberc Lung Dis. 2017;21:75-80.
    PubMed     Abstract available


  620. ZWERLING A, Dowdy D, von Delft A, Taylor H, et al
    Incorporating social justice and stigma in cost-effectiveness analysis: drug-resistant tuberculosis treatment.
    Int J Tuberc Lung Dis. 2017;21:69-74.
    PubMed     Abstract available


  621. BOND V, Floyd S, Fenty J, Schaap A, et al
    Secondary analysis of tuberculosis stigma data from a cluster randomised trial in Zambia and South Africa (ZAMSTAR).
    Int J Tuberc Lung Dis. 2017;21:49-59.
    PubMed     Abstract available


  622. MILLER C, Huston J, Samu L, Mfinanga S, et al
    'It makes the patient's spirit weaker': tuberculosis stigma and gender interaction in Dar es Salaam, Tanzania.
    Int J Tuberc Lung Dis. 2017;21:42-48.
    PubMed     Abstract available


    October 2017
  623. THAKUR C, Verma S, Negi RS, Kumar V, et al
    Lophomonas blattarum co-infection in a patient with multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1185-1187.
    PubMed    


  624. NABIROVA D, Schmid G, Yusupova R, Kantarbayeva M, et al
    Assessment of the quality of anti-tuberculosis medicines in Almaty, Kazakhstan, 2014.
    Int J Tuberc Lung Dis. 2017;21:1161-1168.
    PubMed     Abstract available


  625. REDDY S, Ntoyanto S, Sakadavan Y, Reddy T, et al
    Detecting Mycobacterium tuberculosis using the loop-mediated isothermal amplification test in South Africa.
    Int J Tuberc Lung Dis. 2017;21:1154-1160.
    PubMed     Abstract available


  626. YADAV R, Sharma N, Khaneja R, Agarwal P, et al
    Evaluation of the TB-LAMP assay for the rapid diagnosis of pulmonary tuberculosis in Northern India.
    Int J Tuberc Lung Dis. 2017;21:1150-1153.
    PubMed     Abstract available


  627. LIANG L, Shi R, Liu X, Yuan X, et al
    Interferon-gamma response to the treatment of active pulmonary and extra-pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:1145-1149.
    PubMed     Abstract available


  628. O'CONNOR DE, Frederix K, Saito S, Maama LB, et al
    Pulmonary tuberculosis diagnostic practices among people living with the human immunodeficiency virus in Lesotho.
    Int J Tuberc Lung Dis. 2017;21:1133-1138.
    PubMed     Abstract available


  629. SHARMA SK, Chaubey J, Singh BK, Sharma R, et al
    Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
    Int J Tuberc Lung Dis. 2017;21:1112-1117.
    PubMed     Abstract available


  630. SCHNIPPEL K, Firnhaber C, Ndjeka N, Conradie F, et al
    Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa.
    Int J Tuberc Lung Dis. 2017;21:1106-1111.
    PubMed     Abstract available


  631. MOHR E, Daniels J, Muller O, Furin J, et al
    Missed opportunities for earlier diagnosis of rifampicin-resistant tuberculosis despite access to Xpert(R) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:1100-1105.
    PubMed     Abstract available


  632. JIANG Y, Cao B, Ohmagari N, Wu AH, et al
    Comprehensive understanding of health-seeking behaviour among pulmonary tuberculosis patients in China.
    Int J Tuberc Lung Dis. 2017;21:1094-1099.
    PubMed     Abstract available


  633. BROWN A, Ernst P, Cambule A, Morrow M, et al
    Applying the Care Group model to tuberculosis control: findings from a community-based project in Mozambique.
    Int J Tuberc Lung Dis. 2017;21:1086-1093.
    PubMed     Abstract available


  634. WILD V, Jaff D, Shah NS, Frick M, et al
    Tuberculosis, human rights and ethics considerations along the route of a highly vulnerable migrant from sub-Saharan Africa to Europe.
    Int J Tuberc Lung Dis. 2017;21:1075-1085.
    PubMed     Abstract available


  635. DENHOLM JT
    Strategic partnerships towards tuberculosis elimination.
    Int J Tuberc Lung Dis. 2017;21:1072.
    PubMed    


  636. VARAINE F
    Tuberculosis, human rights and ethics.
    Int J Tuberc Lung Dis. 2017;21:1071.
    PubMed    


    September 2017
  637. METCALFE J, Gerona R, Wen A, Bacchetti P, et al
    An LC-MS/MS-based method to analyze the anti-tuberculosis drug bedaquiline in hair.
    Int J Tuberc Lung Dis. 2017;21:1069-1070.
    PubMed    


  638. COLLINS D, Hafidz F, Mustikawati D
    The economic burden of tuberculosis in Indonesia.
    Int J Tuberc Lung Dis. 2017;21:1041-1048.
    PubMed     Abstract available


  639. MINH HV, Mai VQ, Nhung NV, Hoi LV, et al
    Costs of providing tuberculosis diagnosis and treatment services in Viet Nam.
    Int J Tuberc Lung Dis. 2017;21:1035-1040.
    PubMed     Abstract available


  640. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    High laboratory cost predicted per tuberculosis case diagnosed with increased case finding without a triage strategy.
    Int J Tuberc Lung Dis. 2017;21:1026-1034.
    PubMed     Abstract available


  641. NATHAVITHARANA RR, Daru P, Barrera AE, Mostofa Kamal SM, et al
    FAST implementation in Bangladesh: high frequency of unsuspected tuberculosis justifies challenges of scale-up.
    Int J Tuberc Lung Dis. 2017;21:1020-1025.
    PubMed     Abstract available


  642. YOON C, Chaisson LH, Patel SM, Allen IE, et al
    Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:1013-1019.
    PubMed     Abstract available


  643. DATIKO DG, Yassin MA, Theobald SJ, Cuevas LE, et al
    A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:1002-1007.
    PubMed     Abstract available


  644. LIAO S, Cai C, Huo FM, Wu JN, et al
    Trends in drug-resistant tuberculosis in China: data from a clinical tuberculosis centre.
    Int J Tuberc Lung Dis. 2017;21:990-995.
    PubMed     Abstract available


  645. ZENNER D, Hafezi H, Potter J, Capone S, et al
    Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Int J Tuberc Lung Dis. 2017;21:965-976.
    PubMed     Abstract available


  646. PEDRAZZOLI D, Boccia D, Dodd PJ, Lonnroth K, et al
    Modelling the social and structural determinants of tuberculosis: opportunities and challenges.
    Int J Tuberc Lung Dis. 2017;21:957-964.
    PubMed     Abstract available


  647. CENTIS R, D'Ambrosio L, Migliori GB
    Understanding the multidrug-resistant tuberculosis epidemic in China.
    Int J Tuberc Lung Dis. 2017;21:955.
    PubMed    


    August 2017
  648. THOMAS B, Watson B, Senthil EK, Deepalakshmi A, et al
    Alcohol intervention strategy among tuberculosis patients: a pilot study from South India.
    Int J Tuberc Lung Dis. 2017;21:947-952.
    PubMed     Abstract available


  649. DESHMUKH PR, Mundra A, Dawale A
    Social capital and adverse treatment outcomes of tuberculosis: a case-control study.
    Int J Tuberc Lung Dis. 2017;21:941-946.
    PubMed     Abstract available


  650. RODRIGUEZ CA, Sasse S, Yuengling KA, Azzawi S, et al
    A systematic review of national policies for the management of persons exposed to tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:935-940.
    PubMed     Abstract available


  651. SOUSA M, Gomes M, Gaio AR, Duarte R, et al
    Nosocomial tuberculosis prevention in Portuguese hospitals: a cross-sectional evaluation.
    Int J Tuberc Lung Dis. 2017;21:930-934.
    PubMed     Abstract available


  652. MCDANIEL CJ, Chitnis AS, Barry PM, Shah N, et al
    Tuberculosis trends in California correctional facilities, 1993-2013.
    Int J Tuberc Lung Dis. 2017;21:922-929.
    PubMed     Abstract available


  653. RAJAN JV, Ferrazoli L, Waldman EA, Simonsen V, et al
    Diabetes increases the risk of recent-transmission tuberculosis in household contacts in Sao Paulo, Brazil.
    Int J Tuberc Lung Dis. 2017;21:916-921.
    PubMed     Abstract available


  654. MEHRA M, Kambili C, Potluri R, Rhines A, et al
    Modeling the impact of bedaquiline treatment strategies on the multidrug-resistant tuberculosis burden in India.
    Int J Tuberc Lung Dis. 2017;21:902-909.
    PubMed     Abstract available


  655. CALDERON RI, Velasquez GE, Becerra MC, Zhang Z, et al
    Prevalence of pyrazinamide resistance and Wayne assay performance analysis in a tuberculosis cohort in Lima, Peru.
    Int J Tuberc Lung Dis. 2017;21:894-901.
    PubMed     Abstract available


  656. MELENDEZ J, Philipsen RHHM, Chanda-Kapata P, Sunkutu V, et al
    Automatic versus human reading of chest X-rays in the Zambia National Tuberculosis Prevalence Survey.
    Int J Tuberc Lung Dis. 2017;21:880-886.
    PubMed     Abstract available


  657. BONNET M, Kyakwera C, Kyomugasho N, Atwine D, et al
    Prospective cohort study of the feasibility and yield of household child tuberculosis contact screening in Uganda.
    Int J Tuberc Lung Dis. 2017;21:862-868.
    PubMed     Abstract available


  658. SWEETLAND AC, Kritski A, Oquendo MA, Sublette ME, et al
    Addressing the tuberculosis-depression syndemic to end the tuberculosis epidemic.
    Int J Tuberc Lung Dis. 2017;21:852-861.
    PubMed     Abstract available


  659. KUNST H, Burman M, Arnesen TM, Fiebig L, et al
    Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results.
    Int J Tuberc Lung Dis. 2017;21:840-851.
    PubMed     Abstract available


  660. SHAKOOR S, Hasan R
    Strategies for management of latent tuberculosis in endemic settings: building evidence.
    Int J Tuberc Lung Dis. 2017;21:836.
    PubMed    


  661. ZELLWEGER JP, Posey DL
    Migrant screening for tuberculosis and LTBI in Europe.
    Int J Tuberc Lung Dis. 2017;21:835.
    PubMed    


  662. WANG XH, Ma AG, Han XX, Chen L, et al
    Relationship between Toll-like receptor 4 and type-2 diabetes mellitus complicated by tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:910-915.
    PubMed     Abstract available


    July 2017
  663. HARRIES AD, Ade S, Hoa NB, Satyanarayana S, et al
    Use of inhaled corticosteroids for obstructive lung disease following anti-tuberculosis treatment.
    Int J Tuberc Lung Dis. 2017;21:833-834.
    PubMed    


  664. MOHAMED EI, Mohamed MA, Moustafa MH, Abdel-Mageed SM, et al
    Qualitative analysis of biological tuberculosis samples by an electronic nose-based artificial neural network.
    Int J Tuberc Lung Dis. 2017;21:810-817.
    PubMed     Abstract available


  665. OH KH, Choi H, Kim EJ, Kim HJ, et al
    Depression and risk of tuberculosis: a nationwide population-based cohort study.
    Int J Tuberc Lung Dis. 2017;21:804-809.
    PubMed     Abstract available


  666. NERY JS, Rodrigues LC, Rasella D, Aquino R, et al
    Effect of Brazil's conditional cash transfer programme on tuberculosis incidence.
    Int J Tuberc Lung Dis. 2017;21:790-796.
    PubMed     Abstract available


  667. APOLINARIO D, Ribeiro AI, Krainski E, Sousa P, et al
    Tuberculosis inequalities and socio-economic deprivation in Portugal.
    Int J Tuberc Lung Dis. 2017;21:784-789.
    PubMed     Abstract available


  668. ZHU L, Yang YZ, Guan HY, Cheng SM, et al
    Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
    Int J Tuberc Lung Dis. 2017;21:759-765.
    PubMed     Abstract available


  669. THI SS, Parker DM, Swe LL, Pukrittayakamee S, et al
    Migration histories of multidrug-resistant tuberculosis patients from the Thailand-Myanmar border, 2012-2014.
    Int J Tuberc Lung Dis. 2017;21:753-758.
    PubMed     Abstract available


  670. SHETE PB, Nalugwa T, Farr K, Ojok C, et al
    Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.
    Int J Tuberc Lung Dis. 2017;21:746-752.
    PubMed     Abstract available


  671. DOUGLAS P, Posey DL, Zenner D, Robson J, et al
    Capacity strengthening through pre-migration tuberculosis screening programmes: IRHWG experiences.
    Int J Tuberc Lung Dis. 2017;21:737-745.
    PubMed     Abstract available


  672. DARA M, Sulis G, Centis R, D'Ambrosio L, et al
    Cross-border collaboration for improved tuberculosis prevention and care: policies, tools and experiences.
    Int J Tuberc Lung Dis. 2017;21:727-736.
    PubMed     Abstract available


  673. KUNST H
    Cross-border collaboration in tuberculosis prevention and care in Europe: can we do better?
    Int J Tuberc Lung Dis. 2017;21:717.
    PubMed    


    June 2017
  674. MAGEE MJ, Darchia L, Kipiani M, Chakhaia T, et al
    Smoking behavior and beliefs about the impact of smoking on anti-tuberculosis treatment among health care workers.
    Int J Tuberc Lung Dis. 2017 Jun 29. doi: 10.5588/ijtld.17.0023.
    PubMed     Abstract available


  675. DELGADO E, Monedero I, Bhavaraju R
    Resilience and extensively drug-resistant tuberculosis: the unlikely ally.
    Int J Tuberc Lung Dis. 2017;21:713-716.
    PubMed     Abstract available


  676. SIVAKUMAR P, Marples L, Breen R, Ahmed L, et al
    The diagnostic utility of pleural fluid adenosine deaminase for tuberculosis in a low prevalence area.
    Int J Tuberc Lung Dis. 2017;21:697-701.
    PubMed     Abstract available


  677. TELISINGHE L, Amofa-Sekyi M, Maluzi K, Kaluba-Milimo D, et al
    The sensitivity of the QuantiFERON(R)-TB Gold Plus assay in Zambian adults with active tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:690-696.
    PubMed     Abstract available


  678. BARR DA, Coussens AK, Irvine S, Ritchie ND, et al
    Paradoxical upgrading reaction in extra-pulmonary tuberculosis: association with vitamin D therapy.
    Int J Tuberc Lung Dis. 2017;21:677-683.
    PubMed     Abstract available


  679. VAN DER HEIJDEN YF, Karim F, Mufamadi G, Zako L, et al
    Isoniazid-monoresistant tuberculosis is associated with poor treatment outcomes in Durban, South Africa.
    Int J Tuberc Lung Dis. 2017;21:670-676.
    PubMed     Abstract available


  680. PATSCHE CB, Rudolf F, Mogensen SW, Sifna A, et al
    Low prevalence of malnourishment among household contacts of patients with tuberculosis in Guinea-Bissau.
    Int J Tuberc Lung Dis. 2017;21:664-669.
    PubMed     Abstract available


  681. STENNIS NL, Meissner JS, Bhavnani D, Kreiswirth B, et al
    Tuberculosis disease among Mexico-born individuals living in New York City, 2001-2014.
    Int J Tuberc Lung Dis. 2017;21:657-663.
    PubMed     Abstract available


  682. SNOW K, Hesseling AC, Naidoo P, Graham SM, et al
    Tuberculosis in adolescents and young adults: epidemiology and treatment outcomes in the Western Cape.
    Int J Tuberc Lung Dis. 2017;21:651-657.
    PubMed     Abstract available


  683. KALRA A
    Care seeking and treatment related delay among childhood tuberculosis patients in Delhi, India.
    Int J Tuberc Lung Dis. 2017;21:645-650.
    PubMed     Abstract available


  684. ZIEMELE B, Ranka R, Ozere I
    Pediatric and adolescent tuberculosis in Latvia, 2011-2014: case detection, diagnosis and treatment.
    Int J Tuberc Lung Dis. 2017;21:637-645.
    PubMed     Abstract available


  685. LONNROTH K, Mor Z, Erkens C, Bruchfeld J, et al
    Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points.
    Int J Tuberc Lung Dis. 2017;21:624-637.
    PubMed     Abstract available


  686. DHAVAN P, Dias HM, Creswell J, Weil D, et al
    An overview of tuberculosis and migration.
    Int J Tuberc Lung Dis. 2017;21:610-623.
    PubMed     Abstract available


  687. WALKER IF, Baral SC, Wei X, Huque R, et al
    Multidrug-resistant tuberculosis treatment programmes insufficiently consider comorbid mental disorders.
    Int J Tuberc Lung Dis. 2017;21:603-609.
    PubMed     Abstract available


  688. SEDDON JA, Gie RP
    If you look, you will find: time to challenge the childhood tuberculosis paradigm.
    Int J Tuberc Lung Dis. 2017;21:602.
    PubMed    


  689. RAVIGLIONE MC, Mosca D
    Migrant health and tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:599-600.
    PubMed    


  690. OWUSU-EDUSEI K, Stockbridge EL, Winston CA, Kolasa M, et al
    Tuberculin skin test and interferon-gamma release assay use among privately insured persons in the United States.
    Int J Tuberc Lung Dis. 2017;21:684-689.
    PubMed     Abstract available


    May 2017
  691. J-Y FENG JY, Jarlsberg LG, Salcedo K, Rose J, et al
    Clinical and bacteriological characteristics associated with clustering of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017 May 16. doi: 10.5588/ijtld.16.0510.
    PubMed     Abstract available


  692. ARSCOTT-MILLS T, Masole L, Ncube R, Steenhoff AP, et al
    Survey of health care worker knowledge about childhood tuberculosis in high-burden centers in Botswana.
    Int J Tuberc Lung Dis. 2017;21:586-591.
    PubMed     Abstract available


  693. SCOTT C, Mangan J, Tillova Z, Jensen PA, et al
    Evaluation of the Tuberculosis Infection Control Training Center, Tajikistan, 2014-2015.
    Int J Tuberc Lung Dis. 2017;21:579-585.
    PubMed     Abstract available


  694. ADAMS LV, Basu D, Grande SW, Craig SR, et al
    Barriers to tuberculosis care delivery among miners and their families in South Africa: an ethnographic study.
    Int J Tuberc Lung Dis. 2017;21:571-578.
    PubMed     Abstract available


  695. UKWAJA KN, Alobu I, Gidado M, Onazi O, et al
    Economic support intervention improves tuberculosis treatment outcomes in rural Nigeria.
    Int J Tuberc Lung Dis. 2017;21:564-570.
    PubMed     Abstract available


  696. LOVEDAY M, Ramjee A, Osburn G, Master I, et al
    Drug-resistant tuberculosis in patients with minimal symptoms: favourable outcomes in the absence of treatment.
    Int J Tuberc Lung Dis. 2017;21:556-563.
    PubMed     Abstract available


  697. DALE KD, Globan M, Tay EL, Trauer JM, et al
    Recurrence of tuberculosis in a low-incidence setting without directly observed treatment: Victoria, Australia, 2002-2014.
    Int J Tuberc Lung Dis. 2017;21:550-555.
    PubMed     Abstract available


  698. MAHARAJ B, Gengiah TN, Yende-Zuma N, Gengiah S, et al
    Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.
    Int J Tuberc Lung Dis. 2017;21:537-543.
    PubMed     Abstract available


  699. SSENGOOBA W, Lukoye D, Meehan CJ, Kateete DP, et al
    Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.
    Int J Tuberc Lung Dis. 2017;21:531-536.
    PubMed     Abstract available


  700. SATAKE Y, Nakamura Y, Kono M, Hozumi H, et al
    Type-1 polarised dendritic cells are a potent immunogen against Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:523-530.
    PubMed     Abstract available


  701. RONALD LA, Ling DI, FitzGerald JM, Schwartzman K, et al
    Validated methods for identifying tuberculosis patients in health administrative databases: systematic review.
    Int J Tuberc Lung Dis. 2017;21:517-522.
    PubMed     Abstract available


  702. FENG JY, Jarlsberg LG, Rose J, Grinsdale JA, et al
    Impact of Euro-American sublineages of Mycobacterium tuberculosis on new infections among named contacts.
    Int J Tuberc Lung Dis. 2017;21:509-516.
    PubMed     Abstract available


  703. HO J, Jelfs P, Nguyen PT, Sintchenko V, et al
    Pooling sputum samples to improve the feasibility of Xpert(R) MTB/RIF in systematic screening for tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:503-508.
    PubMed     Abstract available


  704. VAN AART C, Boshuizen H, Dekkers A, Korthals Altes H, et al
    Time lag between immigration and tuberculosis rates in immigrants in the Netherlands: a time-series analysis.
    Int J Tuberc Lung Dis. 2017;21:486-492.
    PubMed     Abstract available


  705. POSEY DL, Marano N, Cetron MS
    Cross-border solutions needed to address tuberculosis in migrating populations.
    Int J Tuberc Lung Dis. 2017;21:485-486.
    PubMed    


  706. YATES TA, Atkinson SH
    Ironing out sex differences in tuberculosis prevalence.
    Int J Tuberc Lung Dis. 2017;21:483-484.
    PubMed    


  707. WORTHAM JM, Goggin M, Mora C, Vandehey L, et al
    Acute kidney injury during treatment for latent tuberculous infection with rifampin.
    Int J Tuberc Lung Dis. 2017;21:596-597.
    PubMed     Abstract available


  708. LANGE B, Khan P, Kalmambetova G, Al-Darraji HA, et al
    Diagnostic accuracy of the Xpert((R)) MTB/RIF cycle threshold level to predict smear positivity: a meta-analysis.
    Int J Tuberc Lung Dis. 2017;21:493-502.
    PubMed     Abstract available


    April 2017
  709. JAIN A, Singh PK, Singh U, Kumar V, et al
    Initial screening of extra-pulmonary tuberculosis using the Xpert MTB/RIF assay improves case detection rates.
    Int J Tuberc Lung Dis. 2017;21:478-480.
    PubMed    


  710. CHONG SG, Herron M, Dorman A, Little M, et al
    Renal amyloidosis complicating multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:476-477.
    PubMed    


  711. BLOK L, Bakker MI, Straetemans M, Gerstel L, et al
    Should active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:475.
    PubMed    


  712. WEBER SF, Belard S, Rai S, Reddy R, et al
    Immune thrombocytopenia secondary to tuberculosis: a case and review of literature.
    Int J Tuberc Lung Dis. 2017;21:466-470.
    PubMed     Abstract available


  713. VALENCIA S, Respeito D, Blanco S, Ribeiro RM, et al
    Tuberculosis drug resistance in Southern Mozambique: results of a population-level survey in the district of Manhica.
    Int J Tuberc Lung Dis. 2017;21:446-451.
    PubMed     Abstract available


  714. ADLER H, Archary M, Mahabeer P, LaRussa P, et al
    Tuberculosis in HIV-infected South African children with complicated severe acute malnutrition.
    Int J Tuberc Lung Dis. 2017;21:438-445.
    PubMed     Abstract available


  715. CARTER KL, Gabrellas AD, Shah S, Garland JM, et al
    Improved latent tuberculosis therapy completion rates in refugee patients through use of a clinical pharmacist.
    Int J Tuberc Lung Dis. 2017;21:432-437.
    PubMed     Abstract available


  716. ARMENTA RF, Collins KM, Strathdee SA, Bulterys MA, et al
    Mycobacterium tuberculosis infection among persons who inject drugs in San Diego, California.
    Int J Tuberc Lung Dis. 2017;21:425-431.
    PubMed     Abstract available


  717. SHAIKH N, Gupte A, Dharmshale S, Pokkali S, et al
    Novel interferon-gamma assays for diagnosing tuberculosis in young children in India.
    Int J Tuberc Lung Dis. 2017;21:412-419.
    PubMed     Abstract available


  718. VAN WYK SS, Lin HH, Claassens MM
    A systematic review of prediction models for prevalent pulmonary tuberculosis in adults.
    Int J Tuberc Lung Dis. 2017;21:405-411.
    PubMed     Abstract available


  719. OWUSU-EDUSEI K, Marks SM, Miramontes R, Stockbridge EL, et al
    Tuberculosis hospitalization expenditures per patient from private health insurance claims data, 2010-2014.
    Int J Tuberc Lung Dis. 2017;21:398-404.
    PubMed     Abstract available


  720. RUPERT S, Vassall A, Raizada N, Khaparde SD, et al
    Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India.
    Int J Tuberc Lung Dis. 2017;21:375-380.
    PubMed     Abstract available


  721. PANDEY S, Chadha VK, Laxminarayan R, Arinaminpathy N, et al
    Estimating tuberculosis incidence from primary survey data: a mathematical modeling approach.
    Int J Tuberc Lung Dis. 2017;21:366-374.
    PubMed     Abstract available


  722. DODD PJ
    Tracking tuberculosis incidence: time to tool up.
    Int J Tuberc Lung Dis. 2017;21:363.
    PubMed    


  723. ADINARAYANAN S, Culp RK, Subramani R, Abbas KM, et al
    Role of bacille Calmette-Guerin in preventing tuberculous infection.
    Int J Tuberc Lung Dis. 2017;21:420-424.
    PubMed     Abstract available


  724. ACUNA-VILLAORDUNA C, Orikiriza P, Nyehangane D, White LF, et al
    Effect of previous treatment and sputum quality on diagnostic accuracy of Xpert((R)) MTB/RIF.
    Int J Tuberc Lung Dis. 2017;21:389-397.
    PubMed     Abstract available


  725. DUNBAR R, Naidoo P, Beyers N, Langley I, et al
    Operational modelling: the mechanisms influencing TB diagnostic yield in an Xpert((R)) MTB/RIF-based algorithm.
    Int J Tuberc Lung Dis. 2017;21:381-388.
    PubMed     Abstract available


    March 2017
  726. ZHANG ZX, Sng LH, Yong Y, Lin LM, et al
    Delays in diagnosis and treatment of pulmonary tuberculosis in AFB smear-negative patients with pneumonia.
    Int J Tuberc Lung Dis. 2017 Mar 16. doi: 10.5588/ijtld.16.0667.
    PubMed     Abstract available


  727. MASJEDI MR, Hosseini M, Aryanpur M, Mortaz E, et al
    The effects of smoking on treatment outcome in patients newly diagnosed with pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:351-356.
    PubMed     Abstract available


  728. BOONYAGARS L, Hirunwiwatkul P, Hurst CP
    CD4 count and risk of anti-tuberculosis drug-associated cutaneous reactions in HIV-infected Thai patients.
    Int J Tuberc Lung Dis. 2017;21:338-344.
    PubMed     Abstract available


  729. DIAS M, Gaio R, Sousa P, Abranches M, et al
    Tuberculosis among the homeless: should we change the strategy?
    Int J Tuberc Lung Dis. 2017;21:327-332.
    PubMed     Abstract available


  730. O'HARA LM, Yassi A, Bryce EA, van Rensburg AJ, et al
    Infection control and tuberculosis in health care workers: an assessment of 28 hospitals in South Africa.
    Int J Tuberc Lung Dis. 2017;21:320-326.
    PubMed     Abstract available


  731. HUERGA H, Bastard M, Kamene M, Wanjala S, et al
    Outcomes from the first multidrug-resistant tuberculosis programme in Kenya.
    Int J Tuberc Lung Dis. 2017;21:314-319.
    PubMed     Abstract available


  732. JAVAID A, Hasan R, Zafar A, Chaudry MA, et al
    Pattern of first- and second-line drug resistance among pulmonary tuberculosis retreatment cases in Pakistan.
    Int J Tuberc Lung Dis. 2017;21:303-308.
    PubMed     Abstract available


  733. FOX GJ, Anh NT, Nhung NV, Loi NT, et al
    Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:297-302.
    PubMed     Abstract available


  734. KAMAKIA R, Kiazyk S, Waruk J, Meyers A, et al
    Potential biomarkers associated with discrimination between latent and active pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:278-285.
    PubMed     Abstract available


  735. NAUSCH N, Lundtoft C, Schulz G, Henckel H, et al
    Multiple cytokines for the detection of Mycobacterium tuberculosis infection in children with tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:270-277.
    PubMed     Abstract available


  736. DONNAN EJ, Coulter C, Simpson G, Clark J, et al
    Paediatric tuberculosis in Queensland, Australia: overrepresentation of cross-border and Indigenous children.
    Int J Tuberc Lung Dis. 2017;21:263-269.
    PubMed     Abstract available


  737. CRANMER LM, Langat A, Ronen K, McGrath CJ, et al
    Integrating tuberculosis screening in Kenyan Prevention of Mother-To-Child Transmission programs.
    Int J Tuberc Lung Dis. 2017;21:256-262.
    PubMed     Abstract available


  738. REICHMAN LB
    The tuberculosis taboo.
    Int J Tuberc Lung Dis. 2017;21:251-255.
    PubMed     Abstract available


  739. KURBANIYAZOVA G, Joncevska M, Kalon S, Kalmambetova G, et al
    Results of Xpert((R)) MTB/RIF implementation in Kyrgyzstan.
    Int J Tuberc Lung Dis. 2017;21:333-337.
    PubMed     Abstract available


  740. ANASTASAKOS V, Skouras V, Moschos C, Tsikrika S, et al
    Patterns of drug resistance among patients with tuberculous pleural effusion in Greece.
    Int J Tuberc Lung Dis. 2017;21:309-313.
    PubMed     Abstract available


  741. MORO RN, Sterling TR, Saukkonen J, Vernon A, et al
    Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.
    Int J Tuberc Lung Dis. 2017;21:286-296.
    PubMed     Abstract available


    February 2017
  742. PRIYADARSHINI P, Tiwari K, Das A, Kumar D, et al
    Evaluation of highly conserved hsp65-specific nested PCR primers for diagnosing Mycobacterium tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:214-217.
    PubMed     Abstract available


  743. MCEBULA V, Crowther NJ, Nagel SE, George JA, et al
    Diabetes and abnormal glucose tolerance in subjects with tuberculosis in a South African urban center.
    Int J Tuberc Lung Dis. 2017;21:208-213.
    PubMed     Abstract available


  744. BRYLA M, Dziankowska-Zaborszczyk E, Maniecka-Bryla I
    Standard expected years of life lost due to tuberculosis in Poland.
    Int J Tuberc Lung Dis. 2017;21:202-207.
    PubMed     Abstract available


  745. CLAASSENS MM, Dunbar R, Yang B, Lombard CJ, et al
    Scanty smears associated with initial loss to follow-up in South African tuberculosis patients.
    Int J Tuberc Lung Dis. 2017;21:196-201.
    PubMed     Abstract available


  746. IZUMI K, Ohkado A, Uchimura K, Kawatsu L, et al
    Evaluation of tuberculosis contact investigations in Japan.
    Int J Tuberc Lung Dis. 2017;21:188-195.
    PubMed     Abstract available


  747. HTET KK, Liabsuetrakul T, Thein S
    Cost-effectiveness of a new strategy to detect pulmonary tuberculosis in household contacts in Myanmar.
    Int J Tuberc Lung Dis. 2017;21:181-187.
    PubMed     Abstract available


  748. GUGLIELMETTI L, Hewison C, Avaliani Z, Hughes J, et al
    Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries.
    Int J Tuberc Lung Dis. 2017;21:167-174.
    PubMed     Abstract available


  749. CHIPINDURO M, Mateveke K, Makamure B, Ferrand RA, et al
    Stool Xpert(R) MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis at primary clinics in Zimbabwe.
    Int J Tuberc Lung Dis. 2017;21:161-166.
    PubMed     Abstract available


  750. CHIANG SS, Roche S, Contreras C, Del Castillo H, et al
    Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study.
    Int J Tuberc Lung Dis. 2017;21:154-160.
    PubMed     Abstract available


  751. LOPEZ C, Bertram-Farough A, Heywood D, Dawson L, et al
    Knowing about you: eliciting dimensions of personhood within tuberculosis care.
    Int J Tuberc Lung Dis. 2017;21:149-153.
    PubMed     Abstract available


  752. PARENT SN, Ehrlich R, Baxter V, Kannemeyer N, et al
    Participatory theatre and tuberculosis: a feasibility study with South African health care workers.
    Int J Tuberc Lung Dis. 2017;21:140-148.
    PubMed     Abstract available


  753. STAGG HR, Lipman MC, McHugh TD, Jenkins HE, et al
    Isoniazid-resistant tuberculosis: a cause for concern?
    Int J Tuberc Lung Dis. 2017;21:129-139.
    PubMed     Abstract available


  754. USDIN M, Dedicoat M, Gajraj R, Harrison P, et al
    Latent tuberculous screening of recent migrants attending language classes: a cohort study and cost analysis.
    Int J Tuberc Lung Dis. 2017;21:175-180.
    PubMed     Abstract available


    January 2017
  755. RIEDER HL, Van Deun A
    Rationale for high-dose isoniazid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:123-124.
    PubMed    


  756. REVES R, Benjamin R
    The cost of the failure to eliminate tuberculosis in the United States.
    Int J Tuberc Lung Dis. 2017;21:120.
    PubMed    


  757. KUMAR NP, Velayutham B, Nair D, Babu S, et al
    Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:93-99.
    PubMed     Abstract available


  758. DAVIS A, Terlikbayeva A, Aifah A, Hermosilla S, et al
    Risks for tuberculosis in Kazakhstan: implications for prevention.
    Int J Tuberc Lung Dis. 2017;21:86-92.
    PubMed     Abstract available


  759. SHAWENO D, Shaweno T, Trauer JM, Denholm JT, et al
    Heterogeneity of distribution of tuberculosis in Sheka Zone, Ethiopia: drivers and temporal trends.
    Int J Tuberc Lung Dis. 2017;21:79-85.
    PubMed     Abstract available


  760. KOURA KG, Trebucq A, Schwoebel V
    Do active case-finding projects increase the number of tuberculosis cases notified at national level?
    Int J Tuberc Lung Dis. 2017;21:73-78.
    PubMed     Abstract available


  761. RUDOLF F, Wagner AJ, Back FM, Gomes VF, et al
    Tuberculosis case finding and mortality prediction: added value of the clinical TBscore and biomarker suPAR.
    Int J Tuberc Lung Dis. 2017;21:67-72.
    PubMed     Abstract available


  762. RAGONNET R, Trauer JM, McBryde ES, Houben RM, et al
    Is IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.
    Int J Tuberc Lung Dis. 2017;21:60-66.
    PubMed     Abstract available


  763. CHABALA C, Chongwe G, Jumbe-Marsden E, Somwe SW, et al
    Missed opportunities for screening child contacts of smear-positive tuberculosis in Zambia, a high-prevalence setting.
    Int J Tuberc Lung Dis. 2017;21:53-59.
    PubMed     Abstract available


  764. EGERE U, Togun T, Sillah A, Mendy F, et al
    Identifying children with tuberculosis among household contacts in The Gambia.
    Int J Tuberc Lung Dis. 2017;21:46-52.
    PubMed     Abstract available


  765. ZELDOW B, Kim S, McSherry G, Cotton MF, et al
    Use of antiretrovirals in HIV-infected children in a tuberculosis prevention trial: IMPAACT P1041.
    Int J Tuberc Lung Dis. 2017;21:38-45.
    PubMed     Abstract available


  766. JERENE D, Abebe W, Taye K, Suarez PG, et al
    Tuberculosis along the continuum of HIV care in a cohort of adolescents living with HIV in Ethiopia.
    Int J Tuberc Lung Dis. 2017;21:32-37.
    PubMed     Abstract available


  767. TUPASI T, Garfin AM, Mangan JM, Orillaza-Chi R, et al
    Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.
    Int J Tuberc Lung Dis. 2017;21:23-31.
    PubMed     Abstract available


  768. WELDEGEBREAL S, Mebrahtu T
    Anti-tuberculosis drug resistance in Ethiopia: systematic review.
    Int J Tuberc Lung Dis. 2017;21:18-22.
    PubMed     Abstract available


  769. BANU S, Rahman MT, Ahmed S, Khatun R, et al
    Multidrug-resistant tuberculosis in Bangladesh: results from a sentinel surveillance system.
    Int J Tuberc Lung Dis. 2017;21:12-17.
    PubMed     Abstract available


  770. NOURZAD S, Jenkins HE, Milstein M, Mitnick CD, et al
    Estimating the global burden of multidrug-resistant tuberculosis among prevalent cases of tuberculosis.
    Int J Tuberc Lung Dis. 2017;21:6-11.
    PubMed     Abstract available


  771. FURIN J, Diacon AH, Andries K
    Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Int J Tuberc Lung Dis. 2017;21:4-5.
    PubMed    


    December 2016
  772. STURKENBOOM MG, Bolhuis MS, Akkerman OW, de Lange WC, et al
    Therapeutic drug monitoring of first-line anti-tuberculosis drugs comprises more than C2h measurements.
    Int J Tuberc Lung Dis. 2016;20:1695-1696.
    PubMed    


  773. VELAYUTHAM B, Nair D, Kannan T, Padmapriyadarsini C, et al
    Factors associated with sputum culture conversion in multidrug-resistant pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1671-1676.
    PubMed     Abstract available


  774. SINGANAYAGAM A, Manalan K, Connell DW, Chalmers JD, et al
    Evaluation of serum inflammatory biomarkers as predictors of treatment outcome in pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1653-1660.
    PubMed     Abstract available


  775. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Abstract available


  776. CONNERS E, Garfein RS, Rodwell TC, Udwadia ZF, et al
    Mobility patterns of persons at risk for drug-resistant tuberculosis in Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1633-1638.
    PubMed     Abstract available


  777. ZELNICK JR, O'Donnell MR, Ahuja SD, Chua A, et al
    Health care provider perspectives on tuberculosis care for foreign-born populations in New York City.
    Int J Tuberc Lung Dis. 2016;20:1625-1632.
    PubMed     Abstract available


  778. BRIGHT-THOMAS RJ, Gondker AR, Morris J, Ormerod LP, et al
    Drug-related hepatitis in patients treated with standard anti-tuberculosis chemotherapy over a 30-year period.
    Int J Tuberc Lung Dis. 2016;20:1621-1624.
    PubMed     Abstract available


  779. RENDELL NL, Batjargal N, Jadambaa N, Dobler CC, et al
    Risk of tuberculosis during pregnancy in Mongolia, a high incidence setting with low HIV prevalence.
    Int J Tuberc Lung Dis. 2016;20:1615-1620.
    PubMed     Abstract available


  780. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Abstract available


  781. SIROKA A, Law I, Macinko J, Floyd K, et al
    The effect of household poverty on tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1603-1608.
    PubMed     Abstract available


  782. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 20012011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Abstract available


  783. JENSEN SG, Lillebaek T, Wilcke T, Pedersen MK, et al
    Impact of contact investigation and tuberculosis screening among high-risk groups in Denmark.
    Int J Tuberc Lung Dis. 2016;20:1580-1587.
    PubMed     Abstract available


  784. CASTRO KG
    Detection and treatment of persons with latent tuberculosis infection: first eliminate the policy-to-practice gap.
    Int J Tuberc Lung Dis. 2016;20:1565.
    PubMed    


  785. TALAVERA-PAULIN M, Garcia-Morales L, Ruiz-Sanchez BP, Caamal-Ley AD, et al
    Active tuberculosis patients have high levels of IgA anti-alpha-crystallin and isocitrate lyase proteins.
    Int J Tuberc Lung Dis. 2016;20:1681-1688.
    PubMed     Abstract available


  786. EL AZBAOUI S, Sabri A, Ouraini S, Hassani A, et al
    Utility of the QuantiFERON(R)-TB Gold In-Tube assay for the diagnosis of tuberculosis in Moroccan children.
    Int J Tuberc Lung Dis. 2016;20:1639-1646.
    PubMed     Abstract available


  787. MBATCHOU NGAHANE BH, Dahirou F, Tchieche C, Wandji A, et al
    Clinical characteristics and outcomes of tuberculosis in Douala, Cameroon: a 7-year retrospective cohort study.
    Int J Tuberc Lung Dis. 2016;20:1609-1614.
    PubMed     Abstract available


  788. MARGALIT I, Block C, Mor Z
    Seasonality of tuberculosis in Israel, 2001-2011.
    Int J Tuberc Lung Dis. 2016;20:1588-1593.
    PubMed     Abstract available


  789. BRUGUERAS S, Orcau A, Millet JP, Espinosa L, et al
    Tuberculosis clinical units improve contact tracing.
    Int J Tuberc Lung Dis. 2016;20:1572-1579.
    PubMed     Abstract available


  790. O'DONNELL MR, Padayatchi N, Metcalfe JZ
    Elucidating the role of clofazimine for the treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:52-57.
    PubMed     Abstract available


  791. NUERMBERGER E
    Evolving strategies for dose optimization of linezolid for treatment of tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:48-51.
    PubMed     Abstract available


  792. STERLING TR
    Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:42-47.
    PubMed     Abstract available


  793. MURRAY S, Mendel C, Spigelman M
    TB Alliance regimen development for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:38-41.
    PubMed     Abstract available


  794. GUPTA R, Wells CD, Hittel N, Hafkin J, et al
    Delamanid in the treatment of multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:33-37.
    PubMed     Abstract available


  795. MILSTEIN M, Brzezinski A, Varaine F, Mitnick CD, et al
    (Re)moving the needle: prospects for all-oral treatment for multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:18-23.
    PubMed     Abstract available


    November 2016
  796. DHOLAKIA Y, Mistry N
    Active tuberculosis case finding in a migrant slum community, Mumbai, India.
    Int J Tuberc Lung Dis. 2016;20:1562.
    PubMed    


  797. LEVIN A, Sklyuev S, Felker I, Tceymach E, et al
    Endobronchial valve treatment of destructive multidrug-resistant tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1539-1545.
    PubMed     Abstract available


  798. PINA RZ, Caleffi-Ferracioli KR, Campanerut-Sa PA, Ghiraldi-Lopez LD, et al
    Pyrazinamide susceptibility testing in Mycobacterium tuberculosis using the fast resazurin microtiter assay plate.
    Int J Tuberc Lung Dis. 2016;20:1535-1538.
    PubMed     Abstract available


  799. ALIPANAH N, Cattamanchi A, Menzies R, Hopewell PC, et al
    Treatment of non-cavitary pulmonary tuberculosis with shortened fluoroquinolone-based regimens: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:1522-1528.
    PubMed     Abstract available


  800. KIM CH, Lim JK, Lee DH, Yoo SS, et al
    Outcomes of standard and tailored anti-tuberculosis regimens in patients with tuberculous pleural effusion.
    Int J Tuberc Lung Dis. 2016;20:1516-1521.
    PubMed     Abstract available


  801. IGLECIAS LM, Puga MA, Pompilio MA, Teles SA, et al
    Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil.
    Int J Tuberc Lung Dis. 2016;20:1509-1515.
    PubMed     Abstract available


  802. IZUMI K, Kawatsu L, Ohkado A, Uchimura K, et al
    Evaluating the impact of health resource reconstruction on improving spatial accessibility of tuberculosis care.
    Int J Tuberc Lung Dis. 2016;20:1501-1508.
    PubMed     Abstract available


  803. LOPEZ AL, Aldaba JG, Ama CG, Sylim PG, et al
    Surveillance for tuberculosis in a rural community in The Philippines.
    Int J Tuberc Lung Dis. 2016;20:1495-1500.
    PubMed     Abstract available


  804. NOESKE J, Nana Yakam A, Abena Foe JL
    Epidemiology of tuberculosis in Cameroon as mirrored in notification data, 2006-2014.
    Int J Tuberc Lung Dis. 2016;20:1489-1494.
    PubMed     Abstract available


  805. DAFTARY A, Padayatchi N
    Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.
    Int J Tuberc Lung Dis. 2016;20:1483-1488.
    PubMed     Abstract available


  806. MIBEI DJ, Kiarie JW, Wairia A, Kamene M, et al
    Treatment outcomes of drug-resistant tuberculosis patients in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1477-1482.
    PubMed     Abstract available


  807. GARCIA-PRATS AJ, du Plessis L, Draper HR, Burger A, et al
    Outcome of culture-confirmed isoniazid-resistant rifampicin-susceptible tuberculosis in children.
    Int J Tuberc Lung Dis. 2016;20:1469-1476.
    PubMed     Abstract available


  808. CHAYA S, Dangor Z, Solomon F, Nzenze SA, et al
    Incidence of tuberculosis meningitis in a high HIV prevalence setting: time-series analysis from 2006 to 2011.
    Int J Tuberc Lung Dis. 2016;20:1457-1462.
    PubMed     Abstract available


  809. TURKOVA A, Chappell E, Chalermpantmetagul S, Negra MD, et al
    Tuberculosis in HIV-infected children in Europe, Thailand and Brazil: paediatric TB-HIV EuroCoord study.
    Int J Tuberc Lung Dis. 2016;20:1448-1456.
    PubMed     Abstract available


  810. JAGANATH D, Lamichhane G, Shah M
    Carbapenems against Mycobacterium tuberculosis: a review of the evidence.
    Int J Tuberc Lung Dis. 2016;20:1436-1447.
    PubMed     Abstract available


  811. UPLEKAR M
    Public-private mix for tuberculosis care and prevention. What progress? What prospects?
    Int J Tuberc Lung Dis. 2016;20:1424-1429.
    PubMed     Abstract available


    October 2016
  812. NUNN A, Tweed C
    Treatment regimens for rifampicin-resistant tuberculosis: highlighting a research gap.
    Int J Tuberc Lung Dis. 2016;20:1418-1419.
    PubMed    


  813. KARAKAS A, Turhan V, Esquinas AM
    Reasons for high mortality rates in patients with pulmonary tuberculosis needing mechanical ventilation.
    Int J Tuberc Lung Dis. 2016;20:1416-1417.
    PubMed    


  814. FRIEDEN TR
    Positive bacteriological results among contacts of patients with active tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1416.
    PubMed    


  815. NAIDOO P, Dunbar R, du Toit E, van Niekerk M, et al
    Comparing laboratory costs of smear/culture and Xpert(R) MTB/RIF-based tuberculosis diagnostic algorithms.
    Int J Tuberc Lung Dis. 2016;20:1377-1385.
    PubMed     Abstract available


  816. ZHAO Q, Xiao X, Lu W, Qiu LX, et al
    Screening diabetes in tuberculosis patients in eastern rural China: a community-based cross-sectional study.
    Int J Tuberc Lung Dis. 2016;20:1370-1376.
    PubMed     Abstract available


  817. WATTANAPOKAYAKIT S, Mushiroda T, Yanai H, Wichukchinda N, et al
    NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
    Int J Tuberc Lung Dis. 2016;20:1364-1369.
    PubMed     Abstract available


  818. THIEL BA, Bark CM, Nakibali JG, van der Kuyp F, et al
    Reader variability and validation of the Timika X-ray score during treatment of pulmonary tuberculosis.
    Int J Tuberc Lung Dis. 2016;20:1358-1363.
    PubMed     Abstract available


  819. PARCHURE R, Kulkarni V, Gangakhedkar R, Swaminathan S, et al
    Treatment outcomes of daily anti-tuberculosis treatment in HIV-infected patients seeking care at a private clinic in India.
    Int J Tuberc Lung Dis. 2016;20:1348-1353.
    PubMed     Abstract available


  820. TOLLEFSON D, Ngari F, Mwakala M, Gethi D, et al
    Under-reporting of sputum smear-positive tuberculosis cases in Kenya.
    Int J Tuberc Lung Dis. 2016;20:1334-1341.
    PubMed     Abstract available


  821. SENKORO M, Kumar AM, Chinnakali P, Mfinanga SG, et al
    Population impact of factors associated with prevalent pulmonary tuberculosis in Tanzania.
    Int J Tuberc Lung Dis. 2016;20:1326-1333.
    PubMed     Abstract available


  822. ENANE LA, Lowenthal ED, Arscott-Mills T, Matlhare M, et al
    Loss to follow-up among adolescents with tuberculosis in Gaborone, Botswana.
    Int J Tuberc Lung Dis. 2016;20:1320-1325.
    PubMed     Abstract available


  823. STILLSON CH, Okatch H, Frasso R, Mazhani L, et al
    'That's when I struggle' ... Exploring challenges faced by care givers of children with tuberculosis in Botswana.
    Int J Tuberc Lung Dis. 2016;20:1314-1319.
    PubMed     Abstract available


  824. SULIS G, Gnanou S, Roggi A, Konseimbo A, et al
    Active tuberculosis case finding among pregnant women: a pilot project in Burkina Faso.
    Int J Tuberc Lung Dis. 2016;20:1306-1308.
    PubMed     Abstract available


  825. MUNANG ML, Browne C, Evans JT, Smith EG, et al
    Programmatic utility of tuberculosis cluster investigation using a social network approach in Birmingham, United Kingdom.
    Int J Tuberc Lung Dis. 2016;20:1300-1305.
    PubMed     Abstract available


  826. TEBRUEGGE M, Buonsenso D, Brinkmann F, Noguera-Julian A, et al
    European shortage of purified protein derivative and its impact on tuberculosis screening practices.
    Int J Tuberc Lung Dis. 2016;20:1293-1299.
    PubMed     Abstract available


  827. TREBUCQ A, Schwoebel V
    Numbers of tuberculosis cases: dreams and reality.
    Int J Tuberc Lung Dis. 2016;20:1288-1292.
    PubMed     Abstract available


  828. LONG R, Lau A
    How R G Ferguson's groundbreaking studies influenced our understanding of tuberculosis reinfection. Where to next?
    Int J Tuberc Lung Dis. 2016;20:1285-1287.
    PubMed    


  829. LONNROTH K, Shah NS, Lange C
    State-of-the-art series on tuberculosis and migration.
    Int J Tuberc Lung Dis. 2016;20:1280-1281.
    PubMed    


    May 2016
  830. NICOLINI A, Perazzo A, Gatto P, Piroddi IM, et al
    A rare adverse reaction to ethambutol: drug-induced haemolytic anaemia.
    Int J Tuberc Lung Dis. 2016;20:704-5.
    PubMed     Abstract available


  831. MUKHERJEE A, Velpandian T, Singla M, Kanhiya K, et al
    Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in HIV-infected Indian children.
    Int J Tuberc Lung Dis. 2016;20:666-72.
    PubMed     Abstract available


  832. RUAN YZ, Li RZ, Wang XX, Wang LX, et al
    The affordability for patients of a new universal MDR-TB coverage model in China.
    Int J Tuberc Lung Dis. 2016;20:638-44.
    PubMed     Abstract available


  833. MODI M, Sharma K, Sharma M, Sharma A, et al
    Multitargeted loop-mediated isothermal amplification for rapid diagnosis of tuberculous meningitis.
    Int J Tuberc Lung Dis. 2016;20:625-30.
    PubMed     Abstract available


  834. MOK Y, Tan TY, Tay TR, Wong HS, et al
    Do we need transbronchial lung biopsy if we have bronchoalveolar lavage Xpert(R) MTB/RIF?
    Int J Tuberc Lung Dis. 2016;20:619-24.
    PubMed     Abstract available


    April 2016
  835. BANDA H, Robinson R, Thomson R, Squire SB, et al
    The 'Practical Approach to Lung Health' in sub-Saharan Africa: a systematic review.
    Int J Tuberc Lung Dis. 2016;20:552-9.
    PubMed     Abstract available


  836. YU J, Wang ZJ, Chen LH, Li HH, et al
    Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis.
    Int J Tuberc Lung Dis. 2016;20:494-9.
    PubMed     Abstract available


  837. WANG F, Hou HY, Wu SJ, Zhu Q, et al
    Using the TBAg/PHA ratio in the T-SPOT((R)).TB assay to distinguish TB disease from LTBI in an endemic area.
    Int J Tuberc Lung Dis. 2016;20:487-93.
    PubMed     Abstract available


  838. SILVA AP, Hill P, Belo MT, Rabelo SG, et al
    Non-completion of latent tuberculous infection treatment among children in Rio de Janeiro State, Brazil.
    Int J Tuberc Lung Dis. 2016;20:479-86.
    PubMed     Abstract available


  839. KELLY AM, Smith B, Luo Z, Given B, et al
    Discordance between patient and clinician reports of adverse reactions to MDR-TB treatment.
    Int J Tuberc Lung Dis. 2016;20:442-7.
    PubMed     Abstract available


    March 2016
  840. COWAN J, Michel C, Manhica I, Mutaquiha C, et al
    Remote monitoring of Xpert(R) MTB/RIF testing in Mozambique: results of programmatic implementation of GxAlert.
    Int J Tuberc Lung Dis. 2016;20:335-41.
    PubMed     Abstract available


    February 2016
  841. YANG HK, Park MJ, Lee JH, Lee CT, et al
    Incidence of toxic optic neuropathy with low-dose ethambutol.
    Int J Tuberc Lung Dis. 2016;20:261-4.
    PubMed     Abstract available


  842. SIDIQ Z, Hanif M, Chopra KK, Khanna A, et al
    Random blinded rechecking of AFB smears in a pilot project at an intermediate reference laboratory.
    Int J Tuberc Lung Dis. 2016;20:252-6.
    PubMed     Abstract available


  843. MBONZE NB, Tabala M, Wenzi LK, Bakoko B, et al
    Xpert((R)) MTB/RIF for smear-negative presumptive TB: impact on case notification in DR Congo.
    Int J Tuberc Lung Dis. 2016;20:240-6.
    PubMed     Abstract available


  844. SABI I, Kabyemera R, Mshana SE, Kidenya BR, et al
    Pulmonary TB bacteriologically confirmed by induced sputum among children at Bugando Medical Centre, Tanzania.
    Int J Tuberc Lung Dis. 2016;20:228-34.
    PubMed     Abstract available


  845. ELIAS D, Akuffo H, Abate E, Mekonnen Y, et al
    Risk of tuberculous infection in adolescents and adults in a rural community in Ethiopia.
    Int J Tuberc Lung Dis. 2016;20:218-22.
    PubMed     Abstract available


  846. KERKHOFF AD, Meintjes G, Opie J, Vogt M, et al
    Anaemia in patients with HIV-associated TB: relative contributions of anaemia of chronic disease and iron deficiency.
    Int J Tuberc Lung Dis. 2016;20:193-201.
    PubMed     Abstract available


  847. BONNET M, Bastard M, du Cros P, Khamraev A, et al
    Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study.
    Int J Tuberc Lung Dis. 2016;20:177-86.
    PubMed     Abstract available


  848. NIKAM C, Patel R, Sadani M, Ajbani K, et al
    Redefining MTBDRplus test results: what do indeterminate results actually mean?
    Int J Tuberc Lung Dis. 2016;20:154-9.
    PubMed     Abstract available


  849. GLAZIOU P, Floyd K, Weil D, Raviglione M, et al
    TB deaths rank alongside HIV deaths as top infectious killer.
    Int J Tuberc Lung Dis. 2016;20:143-4.
    PubMed    


    January 2016
  850. KO Y, Lee HK, Lee YS, Kim MY, et al
    Accuracy of Xpert((R)) MTB/RIF assay compared with AdvanSure TB/NTM real-time PCR using bronchoscopy specimens.
    Int J Tuberc Lung Dis. 2016;20:115-20.
    PubMed     Abstract available


  851. BENERI CA, Aaron L, Kim S, Jean-Philippe P, et al
    Understanding NIH clinical case definitions for pediatric intrathoracic TB by applying them to a clinical trial.
    Int J Tuberc Lung Dis. 2016;20:93-100.
    PubMed     Abstract available


  852. KAPOOR S, Gupta A, Shah M
    Cost-effectiveness of isoniazid preventive therapy for HIV-infected pregnant women in India.
    Int J Tuberc Lung Dis. 2016;20:85-92.
    PubMed     Abstract available


  853. HENSEL RL, Kempker RR, Tapia J, Oladele A, et al
    Increased risk of latent tuberculous infection among persons with pre-diabetes and diabetes mellitus.
    Int J Tuberc Lung Dis. 2016;20:71-8.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: